0000950170-23-004643 | 10-K | XBRL Viewer | Definitive Healthcare Corp

Property and Equipment

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Property and equipment consisted of the following:


(in thousands)	December 31, 2022			December 31, 2021
Computers and software	$	5,924		$	4,744
Furniture and equipment		1,204			1,580
Leasehold improvements		2,134			3,348
		9,262			9,672
Less: accumulated depreciation and amortization		(4,798	)		(4,603	)
Property and equipment, net	$	4,464		$	5,069

Depreciation and amortization expense was $2.2 million, $1.7 million and $1.2 million for the years ended December 31, 2022, 2021 and 2020, respectively.

During the second quarter of 2022, due to office relocations, the Company recorded an impairment charge of $1.0 million, comprised of $0.9 million relating to the operating lease right-of-use assets, and $0.1 million relating to the leasehold improvements. These charges were recognized within Transaction, integration and restructuring expenses in the Company’s consolidated statements of operations. The Company also recorded accelerated depreciation of computer equipment of $0.2 million. In connection with the office relocations, the Company disposed of $1.0 million of fully-depreciated property and equipment in the second quarter of 2022.

Equity-based Compensation

12 Months Ended

Dec. 31, 2022

Share-Based Payment Arrangement [Abstract]

Equity-based Compensation

17.

Equity-based Compensation

Equity-based compensation expense is allocated to all departments in the accompanying consolidated statements of operations based on the recipients of the compensation. A summary of the expense by line item in the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020, is provided in the following table.


	Year Ended December 31,
(in thousands)	2022		2021		2020
Cost of revenue	$	942	$	277	$	62
Sales and marketing		13,508		1,930		473
Product development		7,805		1,070		356
General and administrative		14,179		6,680		856
Total compensation expense	$	36,434	$	9,957	$	1,747

2021 Incentive Equity Plan

The Definitive Healthcare Corp. 2021 Equity Incentive Plan (the “2021 Plan”) was adopted in September 2021. The types of grants available under the 2021 Plan include stock options (both incentive and non-qualified), stock appreciation rights (“SARs”), restricted stock awards (“RSAs”), restricted stock units (“RSUs”), and stock-based awards.

The aggregate number of shares of Class A Common Stock available for grant under the 2021 Plan was 4,942,128 shares at December 31, 2022. The outstanding RSUs have time-based and/or performance-based vesting criteria.

Time-Based RSUs

Outstanding time-based RSUs generally vest partially on the one-year anniversary of each grant and quarterly over the subsequent two- or three-year period.

In connection with the departure of two management-level employees, the Company accelerated the vesting of 6,772 previously unvested time-based RSUs, resulting in incremental stock-based compensation expense of approximately $0.1 million during the fourth quarter of 2022. Upon separation, 21,877 unvested time-based RSUs and 13,889 unvested PSUs were forfeited. None of the previously unvested PSUs were accelerated and, accordingly, no incremental stock-based compensation expense was recognized.

The following table summarizes the Company's unvested time-based activity for the years ended December 31, 2022 and 2021:


	2022					2021
				Weighted					Weighted
	Restricted			Average Grant		Restricted			Average Grant
	Stock Units			Date Fair Value		Stock Units			Date Fair Value
Unvested at beginning of year		1,935,899		$	32.59		—		$	—
Granted		2,457,991		$	20.27		1,965,477		$	32.50
Vested		(716,776	)	$	29.86		—		$	—
Forfeited		(238,727	)	$	25.51		(29,578	)	$	27.00
Unvested at end of year		3,438,387		$	24.82		1,935,899		$	32.59

The Company recognized $27.0 million in stock-based compensation expense associated with time-based RSUs in the year ended December 31, 2022, inclusive of the incremental expense associated with the departing management-level employees, and $4.4 million in the year ended December 31, 2021. Total unrecognized expense for these awards was estimated to be $75.8 million at December 31, 2022, to be recognized over a weighted-average period of approximately 2.7 years.

Performance-Based RSUs (“PSUs”)

The Company periodically grants PSUs to certain members of the Company’s senior management team subject to the satisfaction of annual and cumulative performance conditions and/or market conditions established by the Human Capital Management and Compensation Committee of the Board of Directors of Definitive Healthcare Corp. All PSUs previously granted without market-based vesting conditions were forfeited as of December 31, 2022 as none of the performance targets required for vesting were achieved and all expense that was previously recognized associated with these awards was reversed.

In May 2022, the Company granted PSUs to a member of the executive leadership team with performance criteria related to the relative ranking of the total stockholder return (“TSR”) of the Company’s common stock for the cumulative three-year performance period return relative to the TSR of certain peer companies within the Nasdaq Software & Services Index. TSR will be measured based on the 20-trading-day average closing stock price on the first day of the performance period compared

to the 20-trading-day average closing stock price on the last day of such period, inclusive of applicable cash dividend payments. These PSUs subject to the performance criteria will cliff vest after three years, subject to the satisfaction of the performance criteria and the executive’s continued employment through the performance period. PSUs may vest in a range between 0% and 300%, based on the satisfaction of performance, and no shares will be issued if the minimum applicable performance metric is not achieved. As these PSUs vest based on the achievement of market conditions, the grant date fair values were determined using a Monte-Carlo valuation model. The Monte-Carlo valuation model considered a variety of potential future share prices for the Company as well as its peer companies in the selected market index. Expense for these awards is recognized ratably over the requisite service period based on the fair value of the award.

The following table summarizes the Company's unvested PSU activity for the years ended December 31, 2022 and 2021:


	2022					2021
				Weighted				Weighted
	Restricted			Average Grant		Restricted		Average Grant
	Stock Units			Date Fair Value		Stock Units		Date Fair Value
Unvested at beginning of year		164,351		$	27.00		—	$	—
Granted		125,000		$	54.25		164,351	$	27.00
Vested		—		$	-		—	$	—
Forfeited		(164,351	)	$	27.00		—	$	—
Unvested at end of year		125,000		$	54.25		164,351	$	27.00

The number of PSUs awarded represents the target number of shares of common stock that may be earned; however, the actual number of shares may vary based on the satisfaction of performance criteria. The Company recognized $1.7 million in stock-based compensation expense associated with PSUs in the year ended December 31, 2022, and did not recognize any expense associated with PSUs in the year ended December 31, 2021. Total unrecognized expense for these awards was estimated to be $5.1 million at December 31, 2022, to be recognized over a weighted-average period of approximately 2.0 years.

2019 Incentive Equity Plan

The AIDH Topco, LLC 2019 Equity Incentive Plan (the “2019 Plan”) was utilized prior to the Reorganization Transactions and the IPO for the issuance of equity awards in the form of Class B Units to or on behalf of employees, consultants, directors, managers, or others providing services to the Company. In connection with the Reorganization Transactions and the IPO, unvested Class B Units held directly by employees of the Company or indirectly through AIDH Management Holdings, LLC, were exchanged for unvested Definitive OpCo units (held directly or indirectly through AIDH Management Holdings, LLC) based on their respective participation thresholds and the IPO price of $27.00 per share. The Company no longer grants any awards under the 2019 Plan, though previously granted awards under the 2019 Plan remain outstanding and governed by the 2019 Plan, including unvested units.

In connection with the departure of two management-level employees, the Company accelerated the vesting of 126,350 previously unvested Definitive OpCo units (held indirectly through AIDH Management Holdings, LLC), resulting in incremental stock-based compensation expense of approximately $1.8 million during the fourth quarter of 2022. Upon separation, 81,857 unvested Definitive OpCo units (held indirectly through AIDH Management Holdings, LLC) were forfeited.

The following table summarizes the Company’s unvested unit activity.


	Time-Based
				Weighted
	Non-Vested			Average Grant
	Units			Date Fair Value
Unvested at December 31, 2021		2,756,406		$	2.02
Vested		(1,060,385	)		2.03
Forfeited		(186,872	)		2.03
Unvested at December 31, 2022		1,509,149		$	2.03

The Company recorded $7.7 million in stock-based compensation expense associated with these units in the year ended December 31, 2022, inclusive of the incremental expense associated with the departing management-level employees, and $3.4 million during the year ended December 31, 2021. The Company also recorded $1.9 million in incremental compensation expense in the third quarter of 2021 associated with the acceleration of an equity-based award upon retirement of an executive officer. At December 31, 2022, the Company had approximately $8.2 million of unrecognized unit-based compensation expense for unvested units, which is expected to be recognized over a weighted-average period of approximately 1.7 years.

Accounts Receivable

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Accounts Receivable

Accounts receivable consisted of the following:


(in thousands)	December 31, 2022			December 31, 2021
Accounts receivable	$	59,780		$	44,303
Unbilled receivable		881			430
		60,661			44,733
Less: allowance for doubtful accounts		(1,862	)		(1,397	)
Accounts receivable, net	$	58,799		$	43,336

Accrued Expenses and Other Current Liabilities - Schedule of Accrued Expenses And Other Current Liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Accounts Payable and Accrued Liabilities, Current [Abstract]
Payroll and payroll-related	$ 11,961	$ 10,311
Contingent consideration, current	0	7,500
Sales, franchise and other taxes	3,631	1,876
Other	3,156	2,971
Accrued expenses and other current liabilities	$ 18,748	$ 22,658

Stockholders' Equity and Members' Equity - Summary of Class of Stock (Details) - shares	Dec. 31, 2021	Dec. 31, 2020
Class A Units
Class Of Stock [Line Items]
Authorized, issued and outstanding Class A Units		130,245,990
Issued Class B Units	363,516
Class B Units
Class Of Stock [Line Items]
Authorized Class B Units		8,088,877
Issued Class B Units		3,720,063
Outstanding Class B Units (vested Class B Units)		474,920

Acquisitions and Investments

12 Months Ended

Dec. 31, 2022

Business Combinations [Abstract]

Acquisitions and Investments

On December 22, 2021, Definitive Healthcare, LLC (“DH, LLC”), an indirect wholly owned subsidiary of Definitive Healthcare Corp. made a $40.0 million investment in Analytical Wizards Inc. (“AW” or “Analytical Wizards”), a privately held company. Analytical Wizards automates complex analytic models using tools that expedite efficient big data mining through artificial intelligence (“A.I.”) and machine learning (“M.L.”) to uncover deep insights. In the transaction the Company purchased Series B Convertible Preferred Stock of AW (“Series B Preferred Stock”), representing 35% ownership of AW, and an option to acquire the remaining 65% ownership (the "Purchase Option") for $65.0 million. As of December 31, 2021, the Company determined it did not have a controlling financial interest in AW at transaction close as the Company did not have the right to control the governing body of AW or have control through other contractual rights. At December 31, 2021, because the Series B Preferred Stock and the Purchase Option did not have readily determinable fair values, the Company elected to apply the measurement alternative and adjust the carrying value of the investments in AW for impairments and observable prices in identical or similar equity securities of AW. The Company paid $40.0 million for the Series B Preferred Stock and Purchase Option, which was allocated on a relative fair value basis such that the Series B Preferred Stock and Purchase Option had carrying values of $32.7 million and $7.3 million at the time of the transaction, respectively. The Series B Preferred Stock was recorded in Investments in equity securities and the Purchase Option was recorded in Other assets in the accompanying consolidated balance sheet as of December 31, 2021.

On February 18, 2022, the Company purchased the remaining 65% of AW’s equity for $65.0 million, net of cash acquired and an estimated working capital adjustment and other customary purchase price adjustments (the “AW acquisition”). The Company’s previously held investment and Purchase Option were remeasured at fair value as of the date the Purchase Option was exercised. The remeasurement had an immaterial impact on the consolidated statements of operations for the three months ended March 31, 2022. The Company has included the financial results of Analytical Wizards in the consolidated financial statements from February 18, 2022, the date of acquisition.

Upon the consummation of the acquisition, AW became an indirect wholly owned subsidiary of Definitive Healthcare Corp. The total consideration for the initial investment and subsequent exercise of the Purchase Option was $99.4 million, consisting of $40.0 million for the initial investment paid in December 2021, approximately $58.6 million of cash paid at closing, $0.2 million reimbursement from sellers for working capital adjustments, and up to $5.0 million of contingent consideration, initially valued at $1.0 million. The contingent consideration, which relates to earn-out payments that may be paid out, subject to meeting certain expense control metrics during the two-year period following the closing of the AW acquisition, has an estimated fair value of $1.0 million as of the acquisition date. Pursuant to the Stock Purchase Agreement governing the AW acquisition, $10.0 million of the consideration was deposited into an escrow account to secure certain indemnification claims of DH, LLC. The assets acquired and liabilities assumed were recorded at their estimated preliminary fair values and the results of operations were included in the Company’s consolidated results as of the acquisition date.

The consideration transferred for the transaction is summarized as follows:


(in thousands)
Initial cash investment in December 2021	$	40,000
Cash consideration paid at closing		58,645
Working capital adjustment		(202	)
Contingent consideration		1,000
Purchase price	$	99,443

The contingent consideration is based on the achievement of certain expense control metrics during the two-year period following the acquisition date, with potential earn-out payouts ranging from $0 to $5.0 million. The Company estimated the fair value of the contingent consideration to be $1.0 million as of February 18, 2022, based on the estimated achievement of the expense control metrics and time to payment. The Company estimated the fair value of the contingent consideration to be $2.3 million at December 31, 2022. The contingent consideration was recorded in Other long-term liabilities in the accompanying consolidated balance sheet as of December 31, 2022. Refer to Note 12. Fair Value Measurements.

The purchase price allocations for the AW acquisition are provisional and are based on the information that was available as of the acquisition date to estimate the fair values of assets acquired and liabilities assumed. The purchase price allocations for this acquisition, reported as of December 31, 2022, represent the Company’s best estimates of the fair values and were based upon the information available to us. The provisional measurements of fair value for income taxes payable and deferred taxes set forth below may be subject to change as additional information is received and certain tax returns are finalized. The Company will finalize the purchase price allocations during the first quarter of 2023. Acquisition-date fair values of assets and liabilities pertaining to this business combination have been allocated as follows:


(in thousands) Purchase price allocation:	Preliminary, as previously reported			Measurement period adjustments			As adjusted
Cash	$	2,146		$	—		$	2,146
Accounts receivable		3,575			(50	)		3,525
Prepaid expenses and other current assets		506			300			806
Property and equipment		134			—			134
Intangible assets		46,000			—			46,000
Right-of-use asset, operating leases		832			—			832
Other assets		—			703			703
Accounts payable and accrued expenses		(485	)		(502	)		(987	)
Deferred revenue		(3,691	)		326			(3,365	)
Right-of-use liability, operating leases		(832	)		—			(832	)
Deferred taxes		(10,345	)		67			(10,278	)
Other liabilities		(267	)		(633	)		(900	)
Total assets acquired and liabilities assumed		37,573			211			37,784
Goodwill		62,072			(413	)		61,659
Purchase price	$	99,645		$	(202	)	$	99,443

As a result of the AW acquisition, the Company recorded goodwill, customer relationships, developed software, and tradename of $61.7 million, $39.4 million, $6.1 million, and $0.5 million, respectively, as of the acquisition date. The goodwill recognized includes the fair value of the assembled workforce, which is not recognized as an intangible asset separable from goodwill, and any expected synergies gained through the acquisition. The Company determined that the goodwill resulting from the acquisition is not deductible for tax purposes. All goodwill has been allocated to the Company’s one reportable segment.

Customer relationships represent the estimated fair value of the underlying relationships with the acquired entity’s business customers. The Company valued customer relationships using the income approach, specifically the multi-period excess earnings method. Significant assumptions include estimated attrition rates, discount rates, and tax rates reflecting the different risk profiles of the asset depending upon the acquisition. The value assigned to customer relationships is $39.4 million and is amortized using the annual pattern of cash flows (economic value method) over the estimated 20-year life of this asset.

The developed software represents AW’s two modules. Passport Promotional Analytics helps customers to optimize internal investment and business management by focusing on driving incremental efficiencies in sales, cost management, profit optimization, and productive gains. Passport Planning and Performance helps customers to analyze large data sets in order to proactively predict business outcomes. The Company used the income approach, specifically the relief-from-royalty method, to determine the value of developed software. Significant assumptions include forecast of royalty rate, tax rate, and discount rate. The developed software was valued at $6.1 million and is amortized using the straight-line method over the estimated remaining useful life of 6 years.

The tradename represents the estimated fair value of the registered trade name associated with the AW corporate brand. The Company estimated the fair value of the trademark using a relief from royalty method of the income approach. Significant assumptions include forecast of royalty rate, tax rate, and discount rate. The trademark was valued at $0.5 million and is amortized using the straight-line method over the estimated remaining useful life of 5 years.

The amortization periods for the customer relationships, developed software, and tradenames are 20 years, 6 years, and 5 years, respectively. See Note 9 for the estimated total intangible amortization expense during the next five years.

In connection with the acquisition, the Company recognized acquisition related costs of $1.3 million which were recorded within transaction expenses in the accompanying consolidated statements of operations for the year ended December 31, 2022.

During the year ended December 31, 2022 and 2021, AW’s post-acquisition revenue and net loss on a standalone basis were not material.

Unaudited Pro Forma Supplementary Data as if the transaction had occurred on January 1, 2021:


	For the Year Ended December 31,
(in thousands)	2022			2021
Revenue	$	224,130		$	176,169
Net loss		(22,595	)		(61,125	)

These pro forma results have been prepared for comparative purposes only and do not purport to be indicative of the operating results of the Company that would have been achieved had the acquisition actually taken place on January 1, 2021. In addition, these results are not intended to be a projection of future results and do not reflect events that may occur after the acquisition, including but not limited to revenue enhancements, cost savings or operating synergies that the combined Company may achieve as a result of the acquisition.

2020 Acquisition

On October 27, 2020, the Company completed the purchase of all of the outstanding shares of Monocl Holding Company (“Monocl”), a cloud-based platform with millions of expert profiles, for a total estimated consideration of $46.3 million and up to $60.0 million, consisting of approximately $18.3 million of cash payable at closing, $25.4 million of rollover equity, and up to $15.0 million of contingent consideration. The contingent consideration, which relates to earn-out payments that may be paid out upon the achievement of certain performance targets has an estimated fair value of $2.6 million as of the acquisition date. The assets acquired and liabilities assumed were recorded at their estimated fair values and the results of operations were included in the Company’s consolidated results as of the acquisition date.

The consideration transferred for the transaction is summarized as follows:


(in thousands)
Cash consideration	$	18,307
Equity issuance		25,439
Contingent consideration		2,600
Purchase price	$	46,346

Cash consideration for the acquisition was primarily provided through borrowings under the Company’s credit facility.

The performance targets for the contingent consideration are based on ARR for each of the twelve-month periods ended December 31, 2020 and December 31, 2021. Potential payouts range from $0 to $5.0 million and $0 to $10 million based on ARR of below $8.5 million to over $9.5 million and below $12.0 million to over $16.0 million for each of the twelve month periods ended December 31, 2020 and 2021, respectively.

Based on the achievement of certain ARR targets, the fair value of the contingent consideration was $7.5 million as of December 31, 2021. The Company estimated the fair value of the contingent consideration to be $5.2 million at December 31, 2020 based on the achievement of Annual 2020 ARR targets and the probability of achieving the 2021 targets. Refer to note 9. Fair Value Measurements for more detail.

The purchase accounting for the Monocl acquisition was finalized as of December 31, 2020. The final allocation of the acquisition-date fair values of assets and liabilities pertaining to this business combination as of December 31, 2020, was as follows:


(in thousands)
Purchase price allocation:	October 27, 2020
Cash	$	2,774
Accounts receivable		788
Prepaid expenses and other current assets		614
Property and equipment		20
Intangible assets		18,900
Accounts payable and accrued expenses		(2,137	)
Deferred revenue		(2,884	)
Total assets acquired and liabilities assumed		18,075
Goodwill		28,271
Purchase price	$	46,346

As a result of the Monocl acquisition, the Company recorded goodwill, customer relationships, data, technology, and trademark of $28.3 million, $11.9 million, $3.0 million, $2.6 million and $1.4 million, respectively, as of the acquisition date. The goodwill recognized includes the fair value of the assembled workforce, which is not recognized as an intangible asset separable from goodwill, and any expected synergies gained through the acquisition. The Company determined that the goodwill resulting from the acquisition is not deductible for tax purposes. In connection with the acquisition, the Company also recorded deferred revenue of $2.9 million and a contingent consideration liability of $2.6 million. See Note 12. Fair Value Measurements for more detail on determination of fair value.

Customer relationships represent the estimated fair value of the underlying relationships with the acquired entity’s business customers. The Company valued customer relationships using the income approach, specifically the excess earnings method. Significant assumptions include forecast of revenues, cost of revenues, estimated attrition rates, and discount rates reflecting the different risk profiles of the asset depending upon the acquisition. The value assigned to customer relationships is $11.9 million and is amortized using the annual pattern of cash flows (economic value method) over the estimated 14-year life of this asset.

Data includes proprietary data on medical and scientific expert personnel. The Company used the cost approach, specifically the replacement cost method to value the data. The Fair value of the data was estimated to be $3.0 million and is amortized using the straight-line method over the estimated remaining useful life of 3 years.

The technology recognized includes Monocl’s existing technology and provides users with a cloud-based platform with millions of expert profiles generated using machine learning and tailored algorithms through an online platform. This technology provides the automated collection of content sources, data processing and augmentation, and ultimately the generation of contextually relevant and continuously updated expert profiles. The Company used the income approach, specifically the relief-from-royalty method, to determine the value of technology, which was valued at $2.6 million and is amortized using the straight-line method over the estimated remaining useful life of 8 years.

The trademark represents the estimated fair value of the registered trademarks, logo and domain names associated with the Monocl corporate brand. The Company estimated the fair value of the trademark using a relief from royalty method. Significant assumptions include forecast of royalty rate, company revenues, tax rate, and discount rate. The trademark was valued at $1.4 million and is amortized using the straight-line method over the estimated remaining useful life of 19 years.

The weighted average amortization period for the customer relationships, tradenames, technology, and data is 15 years, 17 years, 8 years and 3 years, respectively. See Note 9 for the estimated total intangible amortization expense during the next five years.

In connection with the acquisition, the Company recognized acquisition related costs of $0.4 million which were recorded within transaction expenses in the accompanying consolidated statements of operations.

The net loss of Monocl is included in the Company’s consolidated results since the date of acquisition. The revenue and net loss of Monocl reflected in the consolidated statements operations for the year ended December 31, 2020 were $1.2 million and $1.6 million, respectively.

Unaudited Pro Forma Supplementary Data


(in thousands)	Year Ended December 31, 2020
Revenue	$	122,333
Net loss		(58,350	)

The unaudited pro forma supplementary data presented in the table above shows the effect of the Monocl acquisition, as if the transactions had occurred at the beginning of fiscal year 2020. The pro forma net loss includes adjustments to amortization expense for the valuation of other intangible assets of $0.8 million and interest expense related to incremental borrowings used to finance the transaction of $1.0 million for the year ended December 31, 2020. Acquisition expenses of $0.4 million were excluded from the pro forma net loss for the year ended December 31, 2020. The unaudited pro forma supplementary data is provided for informational purposes only and should not be construed to be indicative of the Company’s results of operations had the acquisition been consummated on the date assumed or of the Company’s results of operations for any future date.

Revenue - Summary of Deferred Contract Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation of Revenue [Line Items]
Additional amounts deferred	$ 238,558	$ 188,977
Current	14,596	11,667
Total deferred contract costs (deferred commissions)	(15,252)	(14,441)	$ (7,685)
Deferred Contract Costs [Member]
Disaggregation of Revenue [Line Items]
Balance at beginning of year	18,547	8,899
Costs amortized	(8,816)	(4,792)
Additional amounts deferred	15,252	14,440
Balance at end of year	24,983	18,547	$ 8,899
Current	10,387	6,880
Non-current	14,596	11,667
Total deferred contract costs (deferred commissions)	$ 24,983	$ 18,547

Accumulated Other Comprehensive Income - Summary of Changes in Accumulated Balances in Other Comprehensive Income (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Unrealized Gains on Cash Flow Hedges
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	$ 0	$ 0	$ 0
Other comprehensive income (loss) before reclassifications	4,480	0	0
Amounts reclassified from AOCI	(173)
Ending Balance	4,307	0	0
Unrealized Loss on Investments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	0	0	0
Other comprehensive income (loss) before reclassifications	(135)	0	0
Amounts reclassified from AOCI	0
Ending Balance	(135)	0	0
Foreign Currency Translation Adjustments
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	62	(131)	0
Other comprehensive income (loss) before reclassifications	(566)	193	(131)
Amounts reclassified from AOCI	0
Ending Balance	(504)	62	(131)
AOCI Attributable to Parent [Member]
Accumulated Other Comprehensive Income (Loss) [Line Items]
Beginning Balance	62	(131)	0
Other comprehensive income (loss) before reclassifications	3,779	193	(131)
Amounts reclassified from AOCI	(173)
Ending Balance	$ 3,668	$ 62	$ (131)

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References

Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 852
-SubTopic 10
-Section 55
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 310
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 4.E)
-URI https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(31))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(30))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 8: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

+ Details

Fair Value Measurements - Schedule of Reconciliation of Earnout Liabilities Measured at Fair Value on a Recurring Basis Unobservable Inputs (Details) - Fair Value, Inputs, Level 3 - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Fair Value Assets And Liabilities Measured On Recurring And Nonrecurring Basis [Line Items]
Balance at beginning of year	$ 7,500	$ 5,236
Additions	1,000	0
Net change in fair value and other adjustments	1,250	3,764
Payments	(7,500)	(1,500)
Balance at end of year	$ 2,250	$ 7,500

Leases

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Leases

The Company leases real estate in the form of office space facilities. Generally, the term for real estate leases ranges from 1 to 9 years at inception of the contract. Some real estate leases include options to renew that can extend the original term by 5 to 10 years.

Operating lease costs are allocated according to headcount to cost of revenue, sales and marketing, product development and general and administrative expenses in the consolidated statements of operations. As of December 31, 2022, the Company does not have any finance leases.

During the first quarter of 2022, the Company gave notice of its intent to extend one of its office lease facilities for an additional five-year period and the extension was accounted for as a lease modification under ASC 842. Accordingly, the Company recorded a right-of-use asset and corresponding operating lease liability of $6.0 million, which represented the present value of the expected future minimum lease payments. During the quarter ended June 30, 2022, the Company’s executive leadership team approved a program to exit the office lease facility and signed an agreement with the landlord to withdraw the Company’s exercise of the option to extend. As a result, the lease terminated on December 31, 2022. This was accounted for as a lease modification under ASC 842 and the Company reduced the right-of-use asset by $6.0 million in the second quarter of 2022. The Company ceased use of the office facility during the same quarter and accordingly recorded an impairment charge of $0.7 million, which represented the remaining carrying value of the right-of-use asset as of June 30, 2022.

Also during the second quarter of 2022, the Company executed a plan to exit one of its other office facilities by exercising an early termination clause, which was accounted for as a lease modification under ASC 842. The Company ceased use of the office facility during the second quarter and accordingly recorded a $0.2 million impairment charge, which represented the remaining carrying value of the right-of-use asset as of June 30, 2022.

The Company recorded the following lease costs for the year ended December 31, 2022:


(in thousands)	Year Ended December 31, 2022
Lease Cost
Capitalized operating lease cost	$	2,676
Variable lease cost		1
Total lease cost	$	2,677


(in thousands)
Supplemental Cash Flow and Other Information
Cash paid for amounts included in measurement of lease liabilities and capitalized operating leases:
Operating cash flows	$	3,145

Right-of-use assets obtained in exchange for lease liabilities:
Capitalized operating leases	$	982

Lease term and discount rate consisted of the following at December 31, 2022:


	December 31, 2022
Weighted-average remaining lease term (in years):
Capitalized operating leases		5.78

Weighted-average discount rate:
Capitalized operating leases		4.2	%

The table below reconciles the undiscounted future minimum lease payments (displayed by year and in the aggregate) under noncancelable operating leases with terms of more than one year to the total operating lease liabilities recognized on the consolidated balance sheets as of December 31, 2022.


(in thousands)	Capitalized Operating Lease
2023	$	1,960
2024		2,344
2025		2,143
2026		2,071
2027		2,112
Thereafter		2,360
	$	12,990

Imputed interest		1,500
Operating lease liability balance at December 31, 2022	$	11,490

Future aggregate minimum annual lease payments as of December 31, 2021 under the previous lease accounting standard were as follows:


(in thousands)	Operating Lease
2023	$	3,120
2024		1,895
2025		2,282
2026		2,174
2027		2,165
Thereafter		4,805
	$	16,441

Total rent expense, which was allocated according to headcount to cost of revenue, sales and marketing, product development and general and administrative expenses in the consolidated statements of operations, was $2.4 million, $2.8 million, and $1.8 million for the years ended December 31, 2022, 2021, and 2020, respectively.

As of December 31, 2022, the Company has entered into one lease agreement for an office facility in Sweden for a term of four years that has not yet commenced. This lease will require lease payments over the term of approximately $1.8 million.

Consolidated Changes in Member's Equity and Total Equity (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Stockholders' Equity [Abstract]
Beginning Balance	$ 1,503,262	$ 1,195,563	$ 1,216,240
Net Income Loss	(6,037)	(17,677)	0
Distributions to members		989	2,940
contributions		5,500	31,804
Equity-based compensation		300	1,747
Comprehensive loss	(2,431)	(17,626)	0
Ending Balance	$ 1,487,221	$ 1,503,262	$ 1,195,563

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 25: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 29: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 31: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 32: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 34: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 35: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

Retirement Plan	12 Months Ended
Retirement Plan	Dec. 31, 2022
Retirement Benefits [Abstract]
Retirement Plan	18. Retirement Plan The Company has a 401(k) plan covering all employees who have met certain eligibility requirements. The Company made matching contributions in accordance with the plan documents. The Company incurred $3.4 million, $2.3 million and $1.6 million in employer matching contributions during the years ended December 31, 2022, 2021 and 2020, respectively.

- Definition

The entire disclosure for retirement benefits.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 55
-Paragraph 17
-URI https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section S99
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=21916913&loc=d3e273930-122802

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(i)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (o)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (p)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 70
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=49170846&loc=d3e28014-114942

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-URI https://asc.fasb.org/topic&trid=2235017

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 60
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=6414203&loc=d3e39689-114964

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iv)(03)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (q)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(1)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (d)(iii)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (l)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 715
-SubTopic 20
-Section 50
-Paragraph 1
-Subparagraph (r)(2)
-URI https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920

+ Details

Stockholders' Equity and Members' Equity (Tables)

12 Months Ended

Dec. 31, 2022

Members' Equity [Abstract]

Schedule of Stock by Class

The table below provides a summary of the number of Units authorized, issued and outstanding as of December 31, 2020:


	December 31, 2020
Class A Units:
Authorized, issued and outstanding Class A Units		130,245,990
Class B Units:
Authorized Class B Units		8,088,877
Issued Class B Units		3,720,063
Outstanding Class B Units (vested Class B Units)		474,920

- Definition

Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information. Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(28))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 480
-SubTopic 10
-Section S99
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(29))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 5
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.3-04)
-URI https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02(27))
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Accrued Expenses and Other Current Liabilities

12 Months Ended

Dec. 31, 2022

Accounts Payable and Accrued Liabilities, Current [Abstract]

Accrued Expenses and Other Current Liabilities

13.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:


(in thousands)	December 31, 2022		December 31, 2021
Payroll and payroll-related	$	11,961	$	10,311
Contingent consideration, current		—		7,500
Sales, franchise and other taxes		3,631		1,876
Other		3,156		2,971
Accrued expenses and other current liabilities	$	18,748	$	22,658

CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS' EQUITY AND TOTAL EQUITY - USD ($) $ in Thousands	Total	Reorganization Transactions [Member]	IPO [Member]	Secondary offering	Definitive Healthcare Corp. [Member] Secondary offering	Definitive OpCo [Member] IPO [Member]	Definitive OpCo [Member] Secondary offering	Class A Units	Class A Units IPO [Member]	Class A Units Definitive Healthcare Corp. [Member] IPO [Member]	Class A Units Definitive Healthcare Corp. [Member] Secondary offering	Class B Units	Class B Units Definitive OpCo [Member] IPO [Member]	Class B Units Definitive OpCo [Member] Secondary offering	Members Equity	Additional Paid-In Capital	Additional Paid-In Capital Reorganization Transactions [Member]	Additional Paid-In Capital IPO [Member]	Additional Paid-In Capital Secondary offering	Additional Paid-In Capital Definitive Healthcare Corp. [Member] IPO [Member]	Additional Paid-In Capital Definitive Healthcare Corp. [Member] Secondary offering	Additional Paid-In Capital Definitive OpCo [Member] IPO [Member]	Additional Paid-In Capital Definitive OpCo [Member] Secondary offering	Accumulated Deficit	Accumulated Deficit Reorganization Transactions [Member]	Accumulated Other Comprehensive (Loss) Income	Accumulated Other Comprehensive (Loss) Income IPO [Member]	Noncontrolling Interests	Noncontrolling Interests Reorganization Transactions [Member]	Noncontrolling Interests Secondary offering	Previously Reported [Member]	Previously Reported [Member] Reorganization Transactions [Member]	Previously Reported [Member] Members Equity	Previously Reported [Member] Accumulated Other Comprehensive (Loss) Income
Beginning Balance at Dec. 31, 2019	$ 1,216,240							$ 1,271,254				$ 744												$ (55,758)
Beginning Balance (in shares) at Dec. 31, 2019								127,125,435
Net Income Loss	0																							(51,157)
Net loss	(51,157)
Distributions to members prior to Reorganization Transactions	(2,940)																							2,940
contributions	31,804							$ 31,804
Conrtibutions , shares								3,120,555
Equity-based compensation	1,747											$ 1,747
Equity based compensation , shares												474,920
Comprehensive loss	0																									$ (131)
Comprehensive Loss	(131)
Ending Balance at Dec. 31, 2020	1,195,563							$ 1,303,058				$ 2,491												(109,855)		(131)					$ 1,195,563		$ 1,195,694	$ (131)
Ending Balance (in shares) at Dec. 31, 2020								130,245,990				474,920
Net Income Loss	(17,677)	$ (27,914)																							$ (17,677)				$ (10,237)
Net loss	(61,257)
Distributions to members prior to Reorganization Transactions	(989)																											$ (989)			(7,139)		7,139
Net loss prior to Reorganization Transactions																																$ (33,343)	(33,343)
Other comprehensive income prior to Reorganization Transactions			$ 51																								$ 51				142			$ 142
contributions	5,500																														5,500		5,500
Equity-based compensation	300	$ 8,214																											$ 3,151		$ 1,743		$ 1,743
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests	(217,447)							$ 73							$ (1,162,455)	$ 351,074												593,861
Initial effect of the Reorganization Transactions and IPO on noncontrolling interests, Share								72,871,733				61,262,052
Issuance of Class A common stock in IPO, net of costs	380,526		441,418					$ 11	$ 18							380,515		$ 441,400
Issuance of Class A common stock in IPO net of costs, Share								11,000,000	17,888,888
Repurchase of share			$ (63,212)		$ (77,584)	$ (29,600)	$ (61,376)			$ (3)	$ (2)									$ 63,209	$ 77,582	$ 29,600	$ 61,376
Repurchase of share, Shares										(2,497,288)	(2,233,238)		(1,169,378)	(1,766,762)
Equity-based compensation, additional paid in capital																	$ 5,063
Comprehensive loss	(17,626)
Comprehensive Loss	193
Forfeited unvested incentive units												(81,285)
Effect of follow-on offering on tax receivable agreements liability				$ (11,291)																			$ (11,291)
Effect of secondary offering and repurchase on noncontrolling interests																			$ (43,576)											$ 43,576
Allocation of vested incentive units to noncontrolling interests																(694)												694
Ending Balance at Dec. 31, 2021	1,503,262							$ 97								890,724								(17,677)		62		630,056
Ending Balance (in shares) at Dec. 31, 2021								97,030,095				58,244,627
Net Income Loss	(6,037)																							(6,037)				(16,218)
Net loss	(22,255)
Other comprehensive income prior to Reorganization Transactions																										3,606
Other comprehensive income, Noncontrolling Interests	5,494																											1,888
Vested incentive units																(7,955)												7,955
Issuance of Class A Common Stock upon vesting of RSUs, shares								716,776
Issuance of Class A Common Stock upon vesting of RSUs																1,717												(1,717)
Shares withheld related to net share settlement (in shares)								(233,252)
Shares withheld related to net share settlement	(4,116)															(4,116)
Effect of LLC unit exchanges, shares								(7,624,654)				(7,624,654)
Effect of LLC unit exchanges	(18,727)							$ 8								63,481												(82,216)
Equity-based compensation																												12,262
Equity-based compensation, Total equity	36,434
Distributions to noncontrolling interests	(12,871)															4,054												(16,925)
Equity-based compensation, additional paid in capital																24,172
Comprehensive loss	(2,431)
Comprehensive Loss	(832)
Forfeited unvested incentive units												(186,872)
Ending Balance at Dec. 31, 2022	$ 1,487,221							$ 105				$ 0				$ 972,077								$ (23,714)		$ 3,668		$ 535,085
Ending Balance (in shares) at Dec. 31, 2022								105,138,273				50,433,101

Property and Equipment - Additional Information (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Property Plant And Equipment [Line Items]
Depreciation and amortization		$ 40,145	$ 38,679	$ 40,197
Operating lease impairment loss	$ 1,000
property plant and equipment fair value disclosure	1,000
Computer Equipment [Member]
Property Plant And Equipment [Line Items]
Depreciation and amortization	200
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Operating lease impairment loss	100
Right Of Use Assets [Member]
Property Plant And Equipment [Line Items]
Operating lease impairment loss	$ 900
Property Plant And Equipment [Member]
Property Plant And Equipment [Line Items]
Depreciation and amortization		$ 2,200	$ 1,700	$ 1,200

Property and Equipment - Schedule of Property and Equipment (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 9,262	$ 9,672
Less: accumulated depreciation and amortization	(4,798)	(4,603)
Property and equipment, net	4,464	5,069
Computers And Software [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	5,924	4,744
Furniture and Equipment [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	1,204	1,580
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Property, Plant and Equipment, Gross	$ 2,134	$ 3,348

Related parties - Additional Information (Details) - USD ($)		3 Months Ended	12 Months Ended
	Sep. 17, 2021	Jun. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Related Party Transaction [Line Items]
Revenue from related parties			$ 1,500,000	$ 1,000,000.0	$ 400,000
Receivable, related parties			800,000	600,000	100,000
Related party transaction, expenses from transactions with related party				200,000	100,000
Payable, related parties, current			0	0	$ 0
Sale of Stock, Description of Transaction		Richard Booth and Samuel A. Hamood participated in the Directed Share Program and purchased 7,407 and 37,037 shares of Class A Common Stock, respectively.
Stock Issued During Period, Value, New Issues				$ 380,526,000
Minimum [Member]
Related Party Transaction [Line Items]
Related party transaction, expenses from transactions with related party			$ 100,000
Common Class A [Member]
Related Party Transaction [Line Items]
Issuance of Class A common stock in IPO net of costs, Share	17,888,888
Richard Booth [Member] \| Directed Share Program [Member] \| Common Class A [Member]
Related Party Transaction [Line Items]
Share purchased		7,407
Samuel A. Hamood [Member] \| Directed Share Program [Member] \| Common Class A [Member]
Related Party Transaction [Line Items]
Share purchased		37,037
Capital Unit, Class A [Member]
Related Party Transaction [Line Items]
Issuance of Class A common stock in IPO net of costs, Share		363,516
Stock Issued During Period, Value, New Issues		$ 5,800,000
Definitive OpCo [Member]
Related Party Transaction [Line Items]
Related party transaction, expenses from transactions with related party	$ 900,000
Definitive Healthcare Corp. [Member]
Related Party Transaction [Line Items]
Common Stock Capital Shares Underwriters Reserved For Sale At IPO		5.00%

Accumulated Other Comprehensive Income

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Accumulated Other Comprehensive Income

15.

Accumulated Other Comprehensive Income

The following table summarize the changes in accumulated balances of other comprehensive income for the years ended December 31, 2022, 2021 and 2020, respectively.


(in thousands)	Unrealized Gain (Loss) on Cash Flow Hedges			Unrealized Loss on Investments			Foreign Currency Translation Adjustments			Total
Balances as of January 1, 2020	$	—		$	—		$	—		$	—
Other comprehensive loss before reclassifications		—			—			(131	)		(131	)
Balances as of December 31, 2020	$	—		$	—		$	(131	)	$	(131	)
Other comprehensive income before reclassifications		—			—			193			193
Balances as of December 31, 2021	$	—		$	—		$	62		$	62
Other comprehensive income (loss) before reclassifications		4,480			(135	)		(566	)		3,779
Amounts reclassified from AOCI		(173	)		—			—			(173	)
Balances as of December 31, 2022	$	4,307		$	(135	)	$	(504	)	$	3,668

Accumulated Other Comprehensive Income (Tables)

12 Months Ended

Dec. 31, 2022

Stockholders' Equity Note [Abstract]

Summary of Changes in Accumulated Balances in Other Comprehensive Income

The following table summarize the changes in accumulated balances of other comprehensive income for the years ended December 31, 2022, 2021 and 2020, respectively.


(in thousands)	Unrealized Gain (Loss) on Cash Flow Hedges			Unrealized Loss on Investments			Foreign Currency Translation Adjustments			Total
Balances as of January 1, 2020	$	—		$	—		$	—		$	—
Other comprehensive loss before reclassifications		—			—			(131	)		(131	)
Balances as of December 31, 2020	$	—		$	—		$	(131	)	$	(131	)
Other comprehensive income before reclassifications		—			—			193			193
Balances as of December 31, 2021	$	—		$	—		$	62		$	62
Other comprehensive income (loss) before reclassifications		4,480			(135	)		(566	)		3,779
Amounts reclassified from AOCI		(173	)		—			—			(173	)
Balances as of December 31, 2022	$	4,307		$	(135	)	$	(504	)	$	3,668

Leases - Schedule of lease costs (Details) $ in Thousands	12 Months Ended
Leases - Schedule of lease costs (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Lease, Cost [Abstract]
Capitalized operating lease cost	$ 2,676
Variable Lease, Cost	1
Total lease cost	$ 2,677

Summary of Significant Accounting Policies (Tables)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Schedule of Property, Plant, and Equipment Depreciated on Straight - Line Basis

Property and equipment are stated at cost, net of accumulated depreciation and amortization. The assets are depreciated on a straight-line basis over the estimated useful lives as follows:


Furniture and equipment	5 years
Computers and software	3 years
Leasehold improvements	Lesser of the asset life or lease term

Schedule of Estimated Useful Lives of the Assets

The following provides a summary of the estimated useful lives by category of asset.


Customer relationships	14 – 20 years
Technology	6 – 8 years
Tradenames / trademark	5 – 19 years
Data	3 years

Short-term Investments (Tables)

12 Months Ended

Dec. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Schedule of short-term investments

Short-term investments classified as available-for-sale consisted of the following:


	December 31, 2022
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Short-term investments:
US treasuries	$	59,849	$	3	$	(129	)	$	59,723
Agency bonds		6,450		4		(2	)		6,452
Commercial paper		95,831		29		(123	)		95,737
Certificates of deposit		23,034		17		(24	)		23,027
Total short-term investments	$	185,164	$	53	$	(278	)	$	184,939

Derivative Instruments and Hedging Activities - Summary of Fair Values of the Interest Rate Swap (Details) - Interest Rate Swap [Member] $ in Thousands	Dec. 31, 2022 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Short-term derivative asset	$ 3,716
Long-term derivative asset	$ 2,834
Derivative Asset, Current, Statement of Financial Position [Extensible Enumeration]	Prepaid Expense and Other Assets, Current
Derivative Asset, Noncurrent, Statement of Financial Position [Extensible Enumeration]	Other Assets, Noncurrent

Subsequent Events - Additional Information (Details) - Subsequent Event [Member] - Restructuring plan Member $ in Millions	Jan. 12, 2023 USD ($)
Maximum [Member]
Subsequent Event [Line Items]
Restructuring and related cost expected cost1	$ 2.5
Minimum [Member]
Subsequent Event [Line Items]
Restructuring and related cost expected cost1	$ 2.0

Property and Equipment (Table)

12 Months Ended

Dec. 31, 2022

Property, Plant and Equipment [Abstract]

Schedule of Property and Equipment

Property and equipment consisted of the following:


(in thousands)	December 31, 2022			December 31, 2021
Computers and software	$	5,924		$	4,744
Furniture and equipment		1,204			1,580
Leasehold improvements		2,134			3,348
		9,262			9,672
Less: accumulated depreciation and amortization		(4,798	)		(4,603	)
Property and equipment, net	$	4,464		$	5,069

Long Term Debt

12 Months Ended

Dec. 31, 2022

Long-Term Debt, Unclassified [Abstract]

Long-Term Debt

10.

Long-Term Debt

Long-term debt consisted of the following as of December 31, 2022 and 2021, respectively:


	December 31, 2022
(in thousands)	Principal		Unamortized debt issuance costs / financing costs			Total debt, net
2021 Term Loan	$	266,406	$	(2,047	)	$	264,359
Less: current portion of long-term debt							8,594
Long-term debt						$	255,765


	December 31, 2021
(in thousands)	Principal		Unamortized debt issuance costs / financing costs			Total debt, net
2021 Term Loan	$	273,282	$	(2,599	)	$	270,683
Less: current portion of long-term debt							6,875
Long-term debt						$	263,808

2021 Credit Agreement

In September 2021, DH Holdings entered into a credit agreement (the “2021 Credit Agreement”) with Bank of America, N.A., as administrative agent, the other lenders party thereto and the other parties specified therein. The 2021 Credit Agreement provides for (i) a $275.0 million term loan A facility (the “2021 Term Loan”) and (ii) a $75.0 million revolving credit facility (the “2021 Revolving Line of Credit” and, together with the 2021 Term Loan, collectively, the “2021 Credit Facilities”), the proceeds of which were used to repay a portion of the indebtedness outstanding under the 2019 Credit Agreement (described below). Both the 2021 Term Loan and the 2021 Revolving Line of Credit mature on September 17, 2026. The 2021 Credit Facilities include customary affirmative, negative and financial covenants. The 2021 Credit Facilities are guaranteed by all of DH Holdings' wholly owned domestic restricted subsidiaries and AIDH Buyer, LLC, a Delaware limited liability company and the direct parent company of DH Holdings, in each case, subject to customary exceptions, and are secured by a lien on substantially all of the assets of DH Holdings and the guarantors, including a pledge of the equity of DH Holdings, in each case, subject to customary exceptions.

The 2021 Term Loan is subject to annual amortization of principal, payable in equal quarterly installments on the last day of each fiscal quarter, commencing on December 31, 2021 (the “Initial Amortization Date”), equal to approximately 2.5% per annum of the principal amount of the term loans in the first year and second year after the Initial Amortization Date and approximately 5.0% per annum of the principal amount of the term loans in the third year, fourth year and fifth year after the Initial Amortization Date. A balloon payment of approximately $220.0 million will be due at the maturity of the 2021 Term Loan. There was $266.4 million and $273.3 million outstanding on the 2021 Term Loan at December 31, 2022 and 2021. respectively.

DH Holdings is required to pay the lenders under the 2021 Credit Agreement an unused commitment fee of between 0.25% and 0.30% per annum on the undrawn commitments under the 2021 Revolving Line of Credit, depending on the total net leverage ratio, quarterly in arrears. The expense is included in interest expense in the statements of operations. There was no outstanding balance on the 2021 Revolving Line of Credit at December 31, 2022 and 2021.

On October 31, 2022, the Company amended the 2021 Credit Agreement to replace the LIBO rate with Term SOFR plus an applicable rate.

For both the 2021 Term Loan and 2021 Revolving Line of Credit, DH Holdings may elect from several interest rate options based on the Term SOFR Rate or the Base Rate plus an applicable margin. The applicable margin is based on the total leverage ratio. As of December 31, 2022, the effective interest rate was 6.17%.

In connection with the 2021 Credit Agreement, the Company capitalized financing costs totaling $3.5 million, of which $2.8 million related to the 2021 Term Loan facility and $0.8 million related to the 2021 Revolving Line of Credit. The financing costs associated with the 2021 Term Loan facility are recorded as a contra-debt balance in Term loan, net of current portion in the consolidated balance sheets and are amortized over the remaining life of the loan using the effective interest method. The Company amortized capitalized financing costs for the 2021 Credit Agreement through interest expense of $0.7 and $0.2 million for the years ended December 31, 2022 and 2021, respectively. The financing costs associated with the 2021 Revolving Line of Credit are recorded in other assets in the consolidated balance sheets and are amortized over the life of the arrangement. At December 31, 2022 and 2021, the unamortized financing costs were $0.6 million and $0.7 million, respectively.

The expected future principal payments as of December 31, 2022 are as follows:


(in thousands)
2023	$	8,593
2024		13,750
2025		13,750
2026		230,313
	$	266,406

Summary of Significant Accounting Policies

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Basis of Presentation

The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”). The Financial Accounting Standards Board (“FASB”) establishes these principles to ensure financial condition, results of operations, and cash flows are consistently reported. Any reference in these notes to applicable accounting guidance is meant to refer to the authoritative nongovernmental GAAP as found in the FASB Accounting Standards Codification (“ASC”).

Principles of Consolidation

The consolidated financial statements include the accounts of the Company and its consolidated subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.

Use of Estimates in the Preparation of Financial Statements

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates, judgements, and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements, as well as the reported amounts of revenues and expenses during the reporting period. These estimates relate, but are not limited to, revenue recognition, allowance for doubtful accounts, contingencies, valuations and useful lives of intangible assets acquired in business combinations, equity-based compensation, and income taxes. Actual results could differ from those estimates.

Revenue Recognition

The Company derives revenue primarily from subscription license fees charged for access to the Company’s database platform, and professional services. The customer arrangements include a promise to allow customers to access a subscription license to the database platform which is hosted by the Company over the contract period, without allowing the customer to take possession of the subscription license or transfer hosting to a third party.

The Company recognizes revenue in accordance with ASC 606–Revenue from Contracts with Customers, which provides a five-step model for recognizing revenue from contracts with customers. Revenue is recognized upon transfer of control of promised services to customers in an amount that reflects the consideration the Company expects to receive in exchange for those services.

Revenue related to hosted subscription license arrangements, which often include non-distinct professional services, is recognized ratably over the contract term as the customer simultaneously receives and consumes the benefits provided by the Company’s performance. These subscription contracts typically have a term of one to three years and are non-cancellable.

The Company also enters into a limited number of contracts that can include various combinations of professional services, which are generally capable of being distinct and can be accounted for as separate performance obligations. Revenue related to these professional services is insignificant and is recognized at a point in time, when the performance obligations under the terms of the contract are satisfied and control has been transferred to the customer.

When a contract contains multiple performance obligations, the contract transaction price is allocated on a relative standalone selling price (“SSP”) basis to each performance obligation. The Company typically determines SSP based on observable selling prices of its products and services. In instances where SSP is not directly observable, SSP is determined using information that may include market conditions and other observable inputs, or by using the residual approach.

The Company accounts for an arrangement when it has approval and commitment from both parties, the rights are identified, the contract has commercial substance, and collectability of consideration is probable. The Company generally obtains written purchase contracts from its customers for a specified service at a specified price, with a specified term, which constitutes an arrangement. Revenue is recognized at the amount expected to be collected, net of any taxes collected from customers, which are subsequently remitted to governmental authorities. The timing of revenue recognition may not align with the right to invoice the customer, but the Company has determined that in such cases, a significant financing component generally does not exist. The Company has elected the practical expedient that permits an entity not to recognize a significant financing component if the time between the transfer of a good or service and payment is one year or less. Payment terms on

invoiced amounts are typically 30 days. The Company does not offer rights of return for its products and services in the normal course of business, and contracts generally do not include customer acceptance clauses.

The Company arrangements typically do not contain variable consideration. However, certain contracts with customers may include service level agreements that entitle the customer to receive service credits, and in certain cases, service refunds, when defined service levels are not met. These arrangements represent a form of variable consideration, which is considered in the calculation of the transaction price. The Company estimates the amount of variable considerations at the expected value based on its assessment of legal enforceability, anticipated performance and a review of specific transactions, historical experience and market and economic conditions. The Company historically has not experienced any significant incidents that affected the defined levels of reliability and performance as required by the contracts.

Fair Value Measurements

The Company measures assets and liabilities at fair value based on an expected exit price, which represents the amount that would be received on the sale of an asset or paid to transfer a liability in an orderly transaction between market participants. As such, fair value may be based on assumptions that market participants would use in pricing an asset or liability. The authoritative guidance on fair value measurements establishes a consistent framework for measuring fair value on either a recurring or nonrecurring basis whereby inputs, used in valuation techniques, are assigned a hierarchical level as follows:

Level 1 - Observable inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities

Level 2 - Other inputs that are directly or indirectly observable in the marketplace

Level 3 - Unobservable inputs that are supported by little or no market activity, including the Company’s own assumptions in determining fair value.

Cash and Cash Equivalents

The Company considers all short-term, highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

Marketable Securities

All investments in marketable securities are classified as available-for-sale and are reported at fair value with unrealized gains and losses excluded from earnings and reported net of tax in accumulated other comprehensive income, which is a component of stockholders’ equity. Unrealized losses that are determined to be other-than-temporary, based on current and expected market conditions, are recognized in earnings. Declines in fair value determined to be credit related are charged to earnings. The cost of marketable securities sold is determined by the specific identification method.

Concentration of Credit Risk and Significant Customers

Financial instruments that potentially subject the Company to concentrations of credit risk consist principally of cash and cash equivalents and accounts receivable. The Company holds cash at major financial institutions that often exceed Federal Deposit Insurance Corporation (“FDIC”) insured limits. The Company manages its credit risk associated with cash concentrations by concentrating its cash deposits in high quality financial institutions and by periodically evaluating the credit quality of the primary financial institutions holding such deposits. The carrying value of cash approximates fair value. Historically, the Company has not experienced any losses due to such cash concentrations. The Company does not have any off-balance-sheet credit exposure related to its customers.

Concentrations of credit risk with respect to trade account receivables are limited due to the large number of customers comprising the Company’s customer base. No single customer accounted for more than 10% of total net sales or receivables in 2022, 2021 or 2020.

Accounts Receivable, Net and Contract Assets

Accounts receivable are stated at the amount management expects to collect from outstanding balances. Allowances for doubtful accounts are provided for those outstanding balances considered to be uncollectible based upon historical collection experience, changes in customer payment profiles, the aging of receivable balances, and management’s overall evaluation of the outstanding balances at year end. Balances that are still outstanding after management has made reasonable collection efforts are written off through a charge to the allowance for doubtful accounts. At December 31, 2022 and 2021, the allowance for doubtful accounts was $1.9 million and $1.4 million, respectively.

Contract assets represent contractual rights to consideration in the future and are generated when contractual billing schedules differ from the timing of revenue recognition. The Company records accounts receivable when it has the unconditional right to issue an invoice and receive payment regardless of whether revenue has been recognized. If revenue is recognized in advance of the right to invoice, a contract asset (unbilled receivable) is recorded, which is included in accounts receivable, net in the consolidated balance sheets.

Deferred Contract Costs

Certain sales commissions earned by the Company’s employees are considered incremental and recoverable costs of obtaining a contract with a customer. These sales commissions for initial and renewal contracts are capitalized and are included in current portion of deferred contract costs and deferred contract costs, net of current portion. Capitalized amounts also include the associated payroll taxes and other fringe benefits associated with the payments to the Company’s employees.

Costs capitalized related to new revenue contracts are amortized on a straight-line basis over four years, which reflects the average period of benefit, including expected contract renewals. When determining the period of benefit, the Company primarily considered its initial estimated customer life, the technological life of the subscription license, as well as an estimated customer relationship period. Costs capitalized related to renewal contracts are amortized on a straight-line basis over two years, which reflects the average renewal period. Renewal contracts with a term of one year or less are expensed.

The capitalized amounts are recoverable through future revenue streams under all non-cancellable customer contracts. Amortization of capitalized costs to obtain revenue contracts is included in sales and marketing expense in the accompanying consolidated statements of operations. There were no impairments of these costs in the years ended December 31, 2022, 2021 or 2020.

Property and Equipment, Net

Property and equipment are stated at cost, net of accumulated depreciation and amortization. The assets are depreciated on a straight-line basis over the estimated useful lives as follows:


Furniture and equipment	5 years
Computers and software	3 years
Leasehold improvements	Lesser of the asset life or lease term

Upon retirement or sale, the cost of assets disposed and the related accumulated depreciation are removed from the accounts and any resulting gain or loss is recognized as gain or loss on disposal of assets in the consolidated statements of operations. Major replacements and improvements are capitalized, while general repairs and maintenance are charged to expense as incurred.

Leases

The Company, at the inception of the contract, determines whether a contract is or contains a lease. For leases with terms greater than 12 months, the Company records the related operating or finance right of use asset and lease liability at the present value of lease payments over the lease term. The Company is generally not able to readily determine the implicit rate in the lease and therefore uses the determined incremental borrowing rate at lease commencement to determine the present value of lease payments. The incremental borrowing rate represents an estimate of the market interest rate the Company would incur at lease commencement to borrow an amount equal to the lease payments on a collateralized basis over the term of a lease. Renewal options are not included in the measurement of the right of use assets and lease liabilities unless the Company is reasonably certain to exercise the optional renewal periods. Some leases also include early termination options, which can be exercised under specific conditions. Additionally, certain leases contain incentives, such as construction allowances from landlords. These incentives reduce the right-of-use asset related to the lease.

Some of the Company's leases contain rent escalations over the lease term. The Company recognizes expense for operating leases on a straight-line basis over the lease term. The Company’s lease agreements contain variable lease payments for common area maintenance, utility, and taxes. The Company has elected the practical expedient to combine lease and non-lease components for all asset categories. Therefore, the lease payments used to measure the lease liability for these leases include fixed minimum rentals along with fixed non-lease component charges. The Company does not have significant residual value guarantees or restrictive covenants in the lease portfolio.

Derivative Instruments and Hedging Activities

The Company records all derivatives on the balance sheet at fair value. The accounting for changes in the fair value of derivatives depends on the intended use of the derivative, whether the Company has elected to designate a derivative in a hedging relationship and apply hedge accounting and whether the hedging relationship has satisfied the criteria necessary to apply hedge accounting. Derivatives designated and qualifying as a hedge of the exposure to changes in the fair value of an asset, liability, or firm commitment attributable to a particular risk, such as interest rate risk, are considered fair value hedges. Derivatives designated and qualifying as a hedge of the exposure to variability in expected future cash flows, or other types of forecasted transactions, are considered cash flow hedges. Derivatives may also be designated as hedges of the foreign currency exposure of a net investment in a foreign operation. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the recognition of the changes in the fair value of the hedged asset or liability that are attributable to the hedged risk in a fair value hedge or the earnings effect of the hedged forecasted transactions in a cash flow hedge. The Company may enter into derivative contracts that are intended to economically hedge certain of its risk, even though hedge accounting does not apply or the Company elects not to apply hedge accounting. The Company measures the credit risk of its derivative financial instruments that are subject to master netting agreements on a net basis by counterparty portfolio.

Advertising and Promotional Expenses

The Company expenses advertising costs as incurred in accordance with ASC 720—Other Expenses – Advertising Cost. Advertising expenses of $1.6 million, $0.9 million and $0.6 million for the years ended December 31, 2022, 2021 and 2020, respectively, are included in sales and marketing expenses on the consolidated statements of operations.

Software Development Costs

The Company accounts for its software development costs in accordance with the guidance set forth in ASC 350-40—Intangibles – Goodwill and Other – Internal Use Software. The Company capitalizes costs to develop software for internal use incurred during the application development stage. Costs related to preliminary project activities and post implementation activities are expensed as incurred. Capitalized costs of $1.0 million, $0.6 million and $0.1 million for the years ended December 31, 2022, 2021 and 2020, respectively, are included in property and equipment, net.

Acquisitions

The Company accounts for business combinations using the acquisition method in accordance with ASC 805, Business Combinations. Each acquired company’s operating results are included in the Company’s consolidated financial statements starting on the date of acquisition. The Company allocates purchase consideration to the tangible and identifiable intangible assets acquired, and liabilities assumed based on their estimated fair values. The purchase price is determined based on the fair value of the assets transferred, liabilities assumed, and equity interests issued, after considering any transactions that are separate from the business combination. The excess of fair value of purchase consideration over the fair values of the identifiable assets and liabilities is recorded as goodwill. Tangible and identifiable intangible assets acquired and liabilities assumed as of the date of acquisition are recorded at the acquisition date fair value. Such valuations require management to make significant estimates and assumptions, especially with respect to intangible assets and contingent liabilities. Significant estimates in valuing certain intangible assets include, but are not limited to, future expected cash flows from acquired customer bases, acquired technology and acquired trade names, useful lives, royalty rates, and discount rates.

The estimates are inherently uncertain and subject to revision as additional information is obtained during the measurement period for an acquisition, which may last up to one year from the acquisition date. During the measurement period, the Company may record adjustments to the fair value of tangible and intangible assets acquired and liabilities assumed, with a corresponding offset to goodwill. After the conclusion of the measurement period or the final determination of the fair value of assets acquired or liabilities assumed, whichever comes first, any subsequent adjustments are recorded to earnings.

In addition, uncertain tax positions and tax-related valuation allowances assumed in connection with a business combination are initially estimated as of the acquisition date. The Company reevaluates these items based upon the facts and circumstances that existed as of the acquisition date, with any revisions to the Company’s preliminary estimates being recorded to goodwill, provided that the timing is within the measurement period. Subsequent to the measurement period, changes to uncertain tax positions and tax related valuation allowances will be recorded to earnings.

For any given acquisition, the Company may identify certain pre-acquisition contingencies. The Company estimates the fair value of such contingencies, which are included as part of the assets acquired or liabilities assumed, as appropriate.

Differences from these estimates are recorded in the consolidated statement of operations in the period in which they are identified.

Goodwill and Intangible Assets

Goodwill is calculated as the excess of the purchase consideration paid in the acquisition of a business over the fair value of the identifiable assets acquired and liabilities assumed. Goodwill is not amortized and is tested for impairment at the reporting unit level, at least annually, and more frequently if events or circumstances occur that would indicate a potential decline in fair value.

A reporting unit is an operating segment or a component of an operating segment. The Company first assesses qualitative factors to evaluate whether it is more likely than not that the fair value of a reporting unit is less than the carrying amount, or it may elect to bypass such assessment. If it is determined that it is more likely than not that the fair value of the reporting unit is less than its carrying value, or if the Company elects to bypass the qualitative assessment, management will perform a quantitative test by determining the fair value of the reporting unit. The estimated fair value of the reporting unit is based on a combination of an income and market approach. The income approach utilizes a projected discounted cash flow model that includes significant assumptions and estimates, including the discount rate, growth rate, and future financial performance. The market approach utilizes the Company's market capitalization plus an appropriate control premium. Market capitalization is determined by multiplying the number of shares of Class A Common Stock outstanding by the market price of its Class A Common Stock. The control premium is determined by utilizing data from publicly available premium studies for similarly situated public company transactions. If the carrying value of the reporting unit exceeds the fair value, then a goodwill impairment loss is recognized for the difference. The Company performs its annual impairment assessment in the first month of the fourth quarter of each calendar year.

Definite-lived intangible assets are amortized over their estimated useful lives, which represent the period over which the Company expects to realize economic value from the acquired asset(s), using the economic consumption method if anticipated future revenues can be reasonably estimated. The straight-line method is used when future revenues cannot be reasonably estimated. The following provides a summary of the estimated useful lives by category of asset.


Customer relationships	14 – 20 years
Technology	6 – 8 years
Tradenames / trademark	5 – 19 years
Data	3 years

In the fourth quarter of 2022, the Company experienced a decline in its stock price resulting in the total market value of its shares of stock outstanding, its market capitalization, being less than the carrying value of its one reporting unit. Therefore, as of October 1, 2022, the Company elected to bypass the qualitative assessment and determined it appropriate to perform quantitative assessments of the Company’s one reporting unit at both October 1, 2022 and December 31, 2022. The Company elected to conduct its quantitative assessments using a combination of an income and a market approach. Based on the Company’s quantitative assessments performed as of October 1, 2022 and December 31, 2022, the fair value of the reporting unit exceeded its related carrying value. Therefore, the Company concluded no impairment of goodwill during the fourth quarter of 2022. The Company performed the annual assessment and concluded there was no impairment in the years ended December 31, 2021 and 2020.

Impairment of Long-Lived Assets

The Company reviews the carrying value of property and equipment and other long-lived assets, including definite-lived intangible assets and property and equipment, for impairment whenever events and circumstances indicate that the carrying value of an asset may not be recoverable. If estimated undiscounted future cash flows expected to result from its use and eventual disposition are not expected to be adequate to recover the asset’s carrying value, an impairment charge is recorded for the excess of the asset’s carrying value over its estimated fair value.

Deferred Revenue

Deferred revenue consists of customer payments and billings in advance of revenue being recognized from the subscription services. If revenue has not yet been recognized, a contract liability (deferred revenue) is recorded. Deferred revenue that is anticipated to be recognized within the next 12 months is recorded as current portion of deferred revenue and the remaining portion is included in long term liabilities as deferred revenue on the consolidated balance sheets.

Debt Issuance Costs

Costs incurred in connection with the issuance of long-term debt are deferred and amortized as interest expense over the terms of the related debt using the effective interest method for term debt and on a straight-line basis for revolving debt. To the extent that the debt is outstanding, these amounts are reflected in the consolidated balance sheets as direct deductions from the long-term portions of debt, except for the costs related to the Company’s revolving credit facilities, which are presented as a non-current asset on the consolidated balance sheets within other assets. Upon a refinancing or amendment, previously capitalized debt issuance costs are expensed and included in loss on extinguishment of debt, if the Company determines that there has been a substantial modification of the related debt. If the Company determines that there has not been a substantial modification of the related debt, any previously capitalized debt issuance costs are amortized as interest expense over the term of the new debt instrument. As of December 31, 2022 and 2021, the Company had $2.0 million and $2.6 million, respectively, of unamortized deferred financing costs related to its non-revolving credit facilities.

Sales Tax

The Company’s revenues may be subject to local sales taxes in certain states, if applicable. It is the Company’s policy to treat all such taxes on a “net” basis, which means the charges for sales taxes to the Company’s customers are not included in revenues and the remittance of such taxes is not presented as an expense.

Income Taxes

Definitive OpCo is taxed as a partnership. For federal and state income tax purposes, income, losses, and other tax attributes not generated by the HSE, Monocl, or AW subsidiaries generally pass through to the Definitive OpCo members’ individual income tax returns. Additionally, Definitive OpCo may be subject to certain taxes on behalf of its members in certain states.

HSE, AW, and the Monocl subsidiaries are taxed as corporations. Accordingly, these entities account for income taxes by recognizing tax assets and liabilities for the cumulative effect of all the temporary differences between financial statement carrying amounts and the tax basis of assets and liabilities. Deferred taxes for the HSE, AW, and Monocl subsidiaries are determined using enacted federal, state, or foreign income tax rates in effect in the year in which the differences are expected to reverse.

Definitive Healthcare Corp. is subject to U.S. federal, state and local income taxes with respect to its allocable share of any taxable income of Definitive OpCo and will be taxed at the prevailing corporate tax rates. In addition to tax expenses, Definitive Healthcare Corp. will also make payments under the Tax Receivable Agreement, which the Company expects to be significant. The Company anticipates that it will account for the income tax effects and corresponding Tax Receivable Agreement’s effects resulting from future redemptions or exchanges of LLC Units by recognizing an increase in Definitive Healthcare Corp.'s deferred tax assets, based on enacted tax rates at the date of the purchase or exchange.

Further, the Company accounts for amounts payable under the Tax Receivable Agreement in accordance with ASC 450—Contingencies. The amounts to be recorded for both the deferred tax assets and the liability for the Company's obligations under the Tax Receivable Agreement will be estimated at the time of any purchase or exchange as a reduction to shareholders’ equity, and the effects of changes in any of the Company's estimates after this date will be included in net income or loss. Similarly, the effect of subsequent changes in the enacted tax rates will be included in net income or loss.

In assessing the realizability of deferred tax assets of Definitive OpCo and its subsidiaries, management considers the weight of available evidence and whether it is more likely than not that some or all of the deferred tax assets will be realized; when necessary, a valuation allowance is established.

Under the provisions of ASC 740—Income Taxes, as it relates to accounting for uncertainties in tax positions, the Company recognizes the tax benefit of tax positions to the extent that the benefit will more likely than not be realized. The determination as to whether the tax benefit will more likely than not be realized is based upon the technical merits of the tax position as well as consideration of the available facts and circumstances. For the tax years ended December 31, 2022, 2021 and 2020, the Company did not have any uncertain tax positions.

Net Loss Per Share

Net income or loss per share is computed in conformity with the two-class method required for participating securities. The two-class method of computing earnings per share is required for entities that have participating securities. The two-class method is an earnings allocation formula that determines earnings per share for participating securities according to dividends declared (or accumulated) and participation rights in undistributed earnings. The participating securities do not include a contractual obligation to share in losses of the Company and are not included in the calculation of net loss per share in the periods in which a net loss is recorded.

Basic net income or loss per share is computed by dividing the net income or loss by the weighted-average number of common shares of the Company outstanding during the period. Diluted net income or loss per share is computed by giving effect to all potential shares, including exchangeable Definitive OpCo LLC Units and restricted stock units, to the extent dilutive. The Company uses the treasury stock method to calculate potentially dilutive shares, as if they were converted into Common Stock at the beginning of the period. Basic and diluted net income or loss per share was the same for the period presented as the inclusion of all potential shares outstanding would have been anti-dilutive. See Note 20. Loss Per Share for additional information on dilutive securities.

Equity-based Compensation

Equity instruments issued in exchange for services performed by officers, employees, consultants, and directors of the Company are accounted for using a fair-value based method, and the fair value of such equity instruments are recognized as expense in the consolidated statements of operations. The Company has issued restricted stock units (“RSUs”), the fair values of which are determined by the closing stock price on the date of grant, and prior to the IPO, issued profit interest units (“PIUs”) to certain employees and officers with a return threshold that was set based on the fair value of the Company.

For PIUs, fair value was determined using a two-step process. First, the Company’s enterprise value was established using generally accepted valuation methodologies, including discounted cash flow analysis, guideline comparable public company analysis, and comparable transaction method. Second, the enterprise value was allocated among the securities that comprise the capital structure of the Company using an option-pricing method based on the Black-Scholes model. For performance-based units, the Company used a Monte Carlo simulation analysis, which captures the impact of the performance vesting conditions to value the performance-based units. The use of the Black-Scholes model and the Monte Carlo simulation required the Company to make estimates and assumptions, such as expected volatility, expected term and expected risk-free interest rate.

Equity-based compensation expense is measured at the grant date fair value of the stock-based awards and is recognized as expense on a straight-line basis over the requisite service periods, which is generally the vesting period of the respective award. The Company estimates the fair value of each stock-based award on its measurement date using either the current market price of the stock or the Monte Carlo Simulation valuation model. The Monte Carlo Simulation valuation models incorporate assumptions as to stock price volatility, the expected life of options or awards, a risk-free interest rate and dividend yield.

Expense for performance restricted stock units with market-based vesting criteria is recognized based upon the fair value of the awards on the date of grant and the number of shares expected to vest based on the terms of the underlying award agreement and the requisite service periods.

For units and shares which had a performance conditions not tied to market-based criteria, we recognized compensation expense based on the Company’s assessment of the probability that the performance condition(s) would be achieved. Any related compensation expense was recognized when the probability of the event was likely and performance criteria were met. Forfeitures are recognized as they occur.

The Company classifies equity-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient’s salary and related costs are classified.

Adoption of Recently Issued Financial Accounting Standards

In October 2021, the FASB issued ASU No. 2021-08—Business Combinations (Topic 805) – Accounting for Contract Assets and Contract Liabilities from Contracts with Customers. This new accounting standard requires contract assets and contract liabilities (i.e., deferred revenue) acquired in a business combination to be recognized and measured by the acquirer on the acquisition date in accordance with ASC 606—Revenue from Contracts with Customers. The standard requires the acquirer to recognize contract assets and contract liabilities at the same amounts recorded by the acquiree. The new accounting guidance is effective for fiscal years beginning after December 15, 2022, with early adoption permitted. The Company adopted this new accounting guidance effective January 1, 2022. In connection with the acquisition of Analytical Wizards completed in the first

quarter of 2022, the Company recorded contract liabilities of $3.4 million. Refer to Note 3. Acquisitions and Investments for further details.

In March 2020, the FASB issued ASU No. 2020-04—Reference Rate Reform (Topic 848) – Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments of ASU No. 2020-04 are effective for companies as of March 12, 2020 through December 31, 2022. An entity may elect to apply the amendments for contract modifications by Topic or Industry Subtopic as of any date from the beginning of an interim period that includes or is subsequent to March 12, 2020, or prospectively from a date within an interim period that includes or is subsequent to March 12, 2020, up to the date that the financial statements are available to be issued. The amendments in this update apply only to contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform and provide optional expedients and exceptions for applying U.S. GAAP to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. The Company adopted the update effective October 1, 2022, and the adoption did not have a material impact on the Company’s consolidated financial statements.

In December 2019, the FASB issued ASU No. 2019-12—Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes. This standard removes certain exceptions for investments, intra-period allocations and interim tax calculations and adds guidance to reduce complexity in accounting for income taxes. The amendment is effective for fiscal years beginning after December 15, 2021. The Company adopted this new accounting guidance effective January 1, 2022, but the adoption did not have a material impact on the Company’s consolidated financial statements.

In February 2016, the FASB issued ASU No. 2016-02—Leases. The new standard establishes a right-of-use (“ROU”) model that requires a lessee to record a ROU asset and a lease liability on the balance sheet for all leases with terms longer than twelve months. Leases will be classified as either finance or operating, with classification affecting the pattern of expense recognition in the income statement. The FASB subsequently issued supplemental and/or clarifying ASUs inclusive of ASU 2020-05, which updated the effective date for certain non-public companies to annual reporting periods beginning after December 15, 2021. A modified retrospective transition approach is required for capital and operating leases existing at, or entered into after, the beginning of the earliest comparative period presented in the financial statements, or by not adjusting the comparative periods and recording a cumulative effect adjustment as of the adoption date, with certain practical expedients available. As it was previously an Emerging Growth Company prior to 2023 as defined by the JOBS Act of 2012, the Company elected to take the extended transition period and adopt the standard following guidance for non-public entities.

The Company adopted ASU No. 2016-02—Leases effective January 1, 2022 using the modified retrospective transition method. Prior period results will continue to be presented under ASC 840 as it was the accounting standard in effect for such periods. The Company elected to apply the package of practical expedients that allows entities to forgo reassessing at the transition date: (1) whether any expired or existing contracts are or contain leases; (2) lease classification for any expired or existing leases; and (3) whether unamortized initial direct costs for existing leases meet the definition of initial direct costs under the new guidance. The Company did not elect the hindsight practical expedient. The Company elected to use the practical expedient that allows the combination of lease and non-lease contract components in all of its underlying asset categories. Finally, the Company also elected a policy of not recording leases on its consolidated balance sheets when the leases have a term of 12 months or less and the Company is not reasonably certain to elect an option to renew the leased asset. Due to the adoption of this guidance, the Company recognized operating right-of-use assets of $12.7 million and operating lease liabilities of $14.0 million as of the date of adoption. The difference between the right-of-use assets and lease liabilities on the accompanying consolidated balance sheet is primarily due to the accrual for lease payments as a result of straight-line lease expense and unamortized tenant incentive liability balances. The Company did not have any impact to opening retained earnings as a result of the adoption of the guidance. The adoption of this new guidance did not have a material impact on the Company’s results of operations, comprehensive loss, cash flows, liquidity or the Company’s covenant compliance under its existing credit agreement.

Recently Issued Accounting Pronouncements Not Yet Adopted

In June 2016, the FASB issued ASU No. 2016-13—Financial Instruments – Credit Losses (Topic 326) – Measurement of Credit Losses on Financial Instruments. This standard is intended to improve financial reporting by requiring earlier recognition of credit losses on financing receivables and other financial assets in scope, such as trade receivables. The amendment is effective for fiscal years beginning after December 15, 2022. The Company adopted the update effective January 1, 2023 and the adoption of the standard did not have a material impact on the Company's consolidated financial statements.

Retirement Plans - Additional Information (Details) - USD ($) $ in Millions	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Retirement Benefits [Abstract]
Employer matching contributions, amount	$ 3.4	$ 2.3	$ 1.6

Goodwill and Intangible Assets

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Goodwill and Intangible Assets

The carrying amounts of goodwill and intangible assets, as of December 31, 2022 and 2021, consist of the following:


	December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	409,430	$	(128,745	)	$	280,685
Developed technologies		56,965		(25,514	)		31,451
Tradenames		35,914		(7,150	)		28,764
Database		50,215		(40,393	)		9,822
Total finite-lived intangible assets		552,524		(201,802	)		350,722
Goodwill		1,323,102		—			1,323,102
Total goodwill and intangible assets	$	1,875,626	$	(201,802	)	$	1,673,824


	December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	370,030	$	(92,942	)	$	277,088
Developed technologies		51,100		(17,475	)		33,625
Tradenames		35,500		(5,034	)		30,466
Database		43,080		(31,789	)		11,291
Total finite-lived intangible assets		499,710		(147,240	)		352,470
Goodwill		1,261,444		—			1,261,444
Total goodwill and Intangible assets	$	1,761,154	$	(147,240	)	$	1,613,914

Amortization expense associated with finite-lived intangible assets was $54.7 million, $58.2 million, and $58.4 million for the years ended December 31, 2022, 2021 and 2020, respectively, of which $16.8 million, $21.3 million and $19.4 million was included in cost of revenue for each respective period.

Estimated total intangible amortization expense during the next five years and thereafter is as follows:


(in thousands)
2023	$	49,833
2024		46,986
2025		42,420
2026		34,888
2027		28,559
Thereafter		148,036
Total	$	350,722

The carrying amount of goodwill increased by $61.7 million during the year ended December 31, 2022 as a result of the AW acquisition (Note 3).

The Company determined it had one reporting unit. The Company performed its annual impairment assessment in the fourth quarters of 2022, 2021 and 2020 and determined there was no impairment to its goodwill or intangible assets in either year.

Stockholders' Equity and Members' Equity - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020	Oct. 27, 2020
Class Of Stock [Line Items]
Capital units, value		$ 5,800
contributions		5,500	$ 31,804
Proceeds From Member Contributions	$ 0	(5,500)	(6,365)
Equity-based compensation		$ 300	1,747
Preferred stock, shares issued	0
Common Class A
Class Of Stock [Line Items]
Common stock, shares outstanding	105,138,273	97,030,095
Definitive OpCo [Member]
Class Of Stock [Line Items]
Number of shares held	105,133,670	97,030,095
Ownership interest (as a percent)	68.20%	63.60%
Noncontrolling interests (as a percent)	31.80%	36.40%
Definitive OpCo [Member] \| Common Class A
Class Of Stock [Line Items]
Common stock, shares outstanding	7,624,654
Antidilutive securities excluded from computation of earnings per share, amount	483,524
Issuance of common stock shares	483,524
Class A Units
Class Of Stock [Line Items]
Class A units issued		363,516
Capital units, value				$ 25,400
Proceeds From Member Contributions			$ 6,400

Income Taxes - Schedule of Components of Deferred Tax Assets And Liability (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Deferred income tax assets:
Net operating loss carry forwards	$ 52,534	$ 38,540	$ 1,517
Outside partnership basis difference	61,378	44,291	0
Tax receivable agreement	11,358	5,329	0
Other	1,131	824	74
Deferred income tax assets	126,401	88,984	1,591
Less valuation allowance	(187,807)	(164,394)	(1,430)
Deferred income tax assets, net of valuation allowance	(61,406)	(75,410)	(161)
Deferred income tax liabilities:
Goodwill and Intangibles	(14,126)	(91)	0
Deferred revenue and advances	(107)	(229)	0
Deferred income tax liabilities	(14,233)	(320)	0
Net deferred tax (liabilities) assets	(75,639)	(75,730)	(161)
Reported as:
Non-current deferred tax assets (included within Other assets)	98	158	161
Non-current deferred tax liabilities	(75,737)	(75,888)	0
Net deferred tax assets (liabilities)	$ 75,639	$ 75,730	$ 161

Acquisitions and Investments - Summary of Allocation of Purchase Price to the Fair Value of Assets Acquired (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Oct. 27, 2020
Monocl
Cash		$ 2,774
Accounts receivable		788
Prepaid expenses and other current assets		614
Property and equipment		20
Intangible assets		18,900
Accounts payable and accrued expenses		(2,137)
Deferred revenue		(2,884)
Total assets acquired and liabilities assumed		18,075
Goodwill		28,271
Purchase price		$ 46,346
AW acquisition
Cash	$ 2,146
Accounts receivable	3,525
Prepaid expenses and other current assets	806
Property and equipment	134
Intangible assets	46,000
Right-of-use asset, operating leases	832
Other assets	703
Accounts payable and accrued expenses	(987)
Deferred revenue	(3,365)
Right-of-use liability, operating leases	(832)
Deferred taxes	(10,278)
Other liabilities	(900)
Total assets acquired and liabilities assumed	37,784
Goodwill	61,659
Purchase price	99,443
AW acquisition \| Preliminary, as previously reported
Cash	2,146
Accounts receivable	3,575
Prepaid expenses and other current assets	506
Property and equipment	134
Intangible assets	46,000
Right-of-use asset, operating leases	832
Other assets	0
Accounts payable and accrued expenses	(485)
Deferred revenue	(3,691)
Right-of-use liability, operating leases	(832)
Deferred taxes	(10,345)
Other liabilities	(267)
Total assets acquired and liabilities assumed	37,573
Goodwill	62,072
Purchase price	99,645
AW acquisition \| Measurement period adjustments
Cash	0
Accounts receivable	(50)
Prepaid expenses and other current assets	300
Property and equipment	0
Intangible assets	0
Right-of-use asset, operating leases	0
Other assets	703
Accounts payable and accrued expenses	(502)
Deferred revenue	326
Right-of-use liability, operating leases	0
Deferred taxes	(67)
Other liabilities	(633)
Total assets acquired and liabilities assumed	211
Goodwill	(413)
Purchase price	$ (202)

Acquisitions and Investments (Tables)

12 Months Ended

Dec. 31, 2022

Business Acquisition [Line Items]

Summary of Transaction Transferred

The consideration transferred for the transaction is summarized as follows:


(in thousands)
Initial cash investment in December 2021	$	40,000
Cash consideration paid at closing		58,645
Working capital adjustment		(202	)
Contingent consideration		1,000
Purchase price	$	99,443

Summary of Allocation of Purchase Price to the Fair Value of Assets Acquired


(in thousands) Purchase price allocation:	Preliminary, as previously reported			Measurement period adjustments			As adjusted
Cash	$	2,146		$	—		$	2,146
Accounts receivable		3,575			(50	)		3,525
Prepaid expenses and other current assets		506			300			806
Property and equipment		134			—			134
Intangible assets		46,000			—			46,000
Right-of-use asset, operating leases		832			—			832
Other assets		—			703			703
Accounts payable and accrued expenses		(485	)		(502	)		(987	)
Deferred revenue		(3,691	)		326			(3,365	)
Right-of-use liability, operating leases		(832	)		—			(832	)
Deferred taxes		(10,345	)		67			(10,278	)
Other liabilities		(267	)		(633	)		(900	)
Total assets acquired and liabilities assumed		37,573			211			37,784
Goodwill		62,072			(413	)		61,659
Purchase price	$	99,645		$	(202	)	$	99,443

Schedule of Business Acquisition, Pro Forma Information

Unaudited Pro Forma Supplementary Data as if the transaction had occurred on January 1, 2021:


	For the Year Ended December 31,
(in thousands)	2022			2021
Revenue	$	224,130		$	176,169
Net loss		(22,595	)		(61,125	)

Monocl

Business Acquisition [Line Items]

Summary of Transaction Transferred

The consideration transferred for the transaction is summarized as follows:


(in thousands)
Cash consideration	$	18,307
Equity issuance		25,439
Contingent consideration		2,600
Purchase price	$	46,346

Summary of Allocation of Purchase Price to the Fair Value of Assets Acquired

The final allocation of the acquisition-date fair values of assets and liabilities pertaining to this business combination as of December 31, 2020, was as follows:


(in thousands)
Purchase price allocation:	October 27, 2020
Cash	$	2,774
Accounts receivable		788
Prepaid expenses and other current assets		614
Property and equipment		20
Intangible assets		18,900
Accounts payable and accrued expenses		(2,137	)
Deferred revenue		(2,884	)
Total assets acquired and liabilities assumed		18,075
Goodwill		28,271
Purchase price	$	46,346

Schedule of Business Acquisition, Pro Forma Information

Unaudited Pro Forma Supplementary Data


(in thousands)	Year Ended December 31, 2020
Revenue	$	122,333
Net loss		(58,350	)

Loss Per Share - Schedule of Dilutive Securities Excluded from Computation of Diluted Net loss Per Share (Details) - shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Vested and Unvested Units [Member]
Antidilutive securities excluded from computation of earnings per share, amount	50,433,101	58,244,627
Restricted Stock Unit [Member]
Antidilutive securities excluded from computation of earnings per share, amount	3,563,387	2,100,250

Long-Term Debt - Schedule of Long-term Debt (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Debt Instrument [Line Items]
Less: current portion of long-term debt	$ 8,594	$ 6,875
Long-term debt	255,765	263,808
2021 Term Loan [Member]
Debt Instrument [Line Items]
Outstanding principal balance	266,406	273,282
Unamortized debt issuance costs / financing costs	(2,047)	(2,599)
Total debt, net	$ 264,359	$ 270,683

Segment and Geographic Data - Schedule of Long-Lived Assets by Geographic Areas) (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenues From External Customers And Long Lived Assets [Line Items]
Total long-lived assets	$ 4,464	$ 5,069
United States [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Total long-lived assets	3,911	4,705
Rest of world [Member]
Revenues From External Customers And Long Lived Assets [Line Items]
Total long-lived assets	$ 553	$ 364

Derivative Instruments and Hedging Activities - Additional Information (Details)	12 Months Ended
	Dec. 31, 2022 USD ($) Segment	Mar. 31, 2022 Segment	Dec. 31, 2021 USD ($)
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Net pre-tax gains	$ 0		$ 0
Interest Rate Swap [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Number of Interest rate swap agreements \| Segment	2	2
Notional amount	$ 66,600,000
Maturity date	Mar. 31, 2025
Net pre-tax gains	$ 3,700,000
Interest Rate Swap [Member] \| Goldman Sachs Bank USA [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fixed interest rates	1.909%
Interest Rate Swap [Member] \| Bank Of America N A [Member]
Derivative Instruments and Hedging Activities Disclosures [Line Items]
Fixed interest rates	1.9065%

Long Term Debt - Schedule of Debt (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Long-Term Debt, Unclassified [Abstract]
2023	$ 8,593
2024	13,750
2025	13,750
2026	230,313
Long-term Debt, Total	$ 266,406

- Definition

Amount, excluding unamortized premium (discount) and debt issuance cost, of long-term debt. Excludes lease obligation.

+ References + Details

Leases (Tables)

12 Months Ended

Dec. 31, 2022

Leases [Abstract]

Schedule of Lease Costs

The Company recorded the following lease costs for the year ended December 31, 2022:


(in thousands)	Year Ended December 31, 2022
Lease Cost
Capitalized operating lease cost	$	2,676
Variable lease cost		1
Total lease cost	$	2,677


(in thousands)
Supplemental Cash Flow and Other Information
Cash paid for amounts included in measurement of lease liabilities and capitalized operating leases:
Operating cash flows	$	3,145

Right-of-use assets obtained in exchange for lease liabilities:
Capitalized operating leases	$	982

Schedule of Leases Term and Discount Rate

Lease term and discount rate consisted of the following at December 31, 2022:


	December 31, 2022
Weighted-average remaining lease term (in years):
Capitalized operating leases		5.78

Weighted-average discount rate:
Capitalized operating leases		4.2	%

Schedule Of Future Minimum Payments For Operating Leases


(in thousands)	Capitalized Operating Lease
2023	$	1,960
2024		2,344
2025		2,143
2026		2,071
2027		2,112
Thereafter		2,360
	$	12,990

Imputed interest		1,500
Operating lease liability balance at December 31, 2022	$	11,490

Schedule of Maturities of Lease Liabilities

Future aggregate minimum annual lease payments as of December 31, 2021 under the previous lease accounting standard were as follows:


(in thousands)	Operating Lease
2023	$	3,120
2024		1,895
2025		2,282
2026		2,174
2027		2,165
Thereafter		4,805
	$	16,441

Leases - Schedule of maturities of lease liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2023	$ 1,960	$ 3,120
2024	2,344	1,895
2025	2,143	2,282
2026	2,071	2,174
2027	2,112	2,165
Thereafter	2,360	4,805
Total undiscounted future minimum lease payments	$ 12,990	$ 16,441

Short-term Investments - Schedule of short-term Investments (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Debt Securities, Available-for-Sale [Line Items]
Amortised cost	$ 185,164
Gross unrealised gains	53
Gross unrealized losses	(278)
Fair value	184,939
U.S. Treasuries [Member]
Debt Securities, Available-for-Sale [Line Items]
Amortised cost	59,849
Gross unrealised gains	3
Gross unrealized losses	(129)
Fair value	59,723
Agency Bonds [Member]
Debt Securities, Available-for-Sale [Line Items]
Amortised cost	6,450
Gross unrealised gains	4
Gross unrealized losses	(2)
Fair value	6,452
Commercial Paper [Member]
Debt Securities, Available-for-Sale [Line Items]
Amortised cost	95,831
Gross unrealised gains	29
Gross unrealized losses	(123)
Fair value	95,737
Certificates of Deposit [Member]
Debt Securities, Available-for-Sale [Line Items]
Amortised cost	23,034
Gross unrealised gains	17
Gross unrealized losses	(24)
Fair value	$ 23,027

Related Parties

12 Months Ended

Dec. 31, 2022

Related Parties

22.

Related Parties

The Company has engaged in revenue transactions within the ordinary course of business with entities affiliated with its private equity sponsors and with members of the Company’s board of directors. During each of the years ended December 31, 2022, 2021 and 2020, the Company recorded revenue of $1.5 million, $1.0 million, and $0.4 million respectively. The associated receivable for the revenue transactions amounted to $0.8 million, $0.6 million, and $0.1 million at December 31, 2022, 2021 and 2020, respectively.

Prior to the Reorganization Transactions described in Note 1, the Company reimbursed its private equity sponsors for services and any related travel and out-of-pocket expenses. During the years ended December 31, 2021 and 2020, the Company had expenses for services, travel, and out-of-pocket expenses to its private equity sponsors of $0.2 million and $0.1 million, respectively. During the year ended December 31, 2022, the Company paid less than $0.1 million to related parties within the ordinary course of business. There were no associated payables for the service transactions at December 31, 2022, 2021, and 2020.

On September 17, 2021, Definitive OpCo entered into an agreement to reimburse approximately $0.9 million in aggregate documented expenses incurred by Advent, 22C Capital, Spectrum Equity, Jason Krantz, and MHDH AB in connection with the Reorganization Transactions. The amounts were paid in the fourth quarter of 2021.

During the second quarter of 2021, the Company issued 363,516 new Class A units worth $5.8 million to members of the Company's board of directors. Further, in connection with Definitive Healthcare’s IPO, the underwriters reserved 5% of the common shares for sale at the initial offering price to the Company’s directors, officers and selected senior managers (the “Directed Share Program”). Richard Booth and Samuel A. Hamood participated in the Directed Share Program and purchased 7,407 and 37,037 shares of Class A Common Stock, respectively.

Goodwill and Intangible Assets - Additional Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	$ 54,711	$ 58,196	$ 58,429
Amortization	16,759	21,268	19,383
Impairment of goodwill	0	0	0
Aw Acquisition [Member]
Finite Lived Intangible Assets [Line Items]
Goodwill, Period Increase (Decrease)	61,700
Finite Lived Intangible Assets [Member]
Finite Lived Intangible Assets [Line Items]
Amortization of intangible assets	54,700	58,200	58,400
Amortization	$ 16,800	$ 21,300	$ 19,400

Summary of Significant Accounting Policies - Schedule of Property, Plant, and Equipment Depreciated on Straight - Line Basis (Details)	12 Months Ended
	Dec. 31, 2022
Furniture and Equipment [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Net	5 years
Computers and Software [Member]
Property Plant And Equipment [Line Items]
Property and Equipment, Net	3 years
Leasehold Improvements [Member]
Property Plant And Equipment [Line Items]
Leasehold improvements	Lesser of the asset life or lease term

Revenue

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Revenue

The Company disaggregates revenue from its arrangements with customers by type of service as it believes these categories best depict how the nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factors.

The following table represents a disaggregation of revenue from arrangements with customers for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
(in thousands)	2022		2021		2020
Subscription services	$	217,024	$	164,564	$	117,080
Professional services		5,629		1,590		1,237
Total revenue	$	222,653	$	166,154	$	118,317

The opening and closing balances of the Company’s receivables, deferred contract costs and contract liabilities from contracts with customers are as follows:


(in thousands)	December 31, 2022		December 31, 2021
Accounts receivable, net	$	58,799	$	43,336
Deferred contract costs		10,387		6,880
Long-term deferred contract costs		14,596		11,667
Deferred revenues		99,928		84,023

Deferred Contract Costs

A summary of the activity impacting the deferred contract costs during the years ended December 31, 2022 and 2021 is presented below:


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	18,547		$	8,899
Costs amortized		(8,816	)		(4,792	)
Additional amounts deferred		15,252			14,440
Balance at end of year		24,983			18,547
Classified as:
Current		10,387			6,880
Non-current		14,596			11,667
Total deferred contract costs (deferred commissions)	$	24,983		$	18,547

Contract Liabilities

A summary of the activity impacting deferred revenue balances during the years ended December 31, 2022 and 2021

is presented below:


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	84,023		$	61,200
Revenue recognized		(222,653	)		(166,154	)
Additional amounts deferred		238,558			188,977
Balance at end of year	$	99,928		$	84,023

Remaining Performance Obligations

Transaction price allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and unbilled amounts that will be recognized as revenue in future periods. Transaction price allocated to remaining performance obligations is influenced by several factors, including seasonality, the timing of renewals, and disparate contract terms. Revenue allocated to remaining performance obligations represents contracted revenue that has not yet been recognized, which includes unearned revenue and backlog. The Company’s backlog represents installment billings for periods beyond the current billing cycle. The majority of the Company’s noncurrent remaining performance obligations will be recognized in the next 13 to 36 months.

The remaining performance obligations consisted of the following:


(in thousands)	December 31, 2022		December 31, 2021
Current	$	183,527	$	155,134
Non-current		93,464		95,354
Total	$	276,991	$	250,488

- Definition

The entire disclosure of revenue from contract with customer to transfer good or service and to transfer nonfinancial asset. Includes, but is not limited to, disaggregation of revenue, credit loss recognized from contract with customer, judgment and change in judgment related to contract with customer, and asset recognized from cost incurred to obtain or fulfill contract with customer. Excludes insurance and lease contracts.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-URI https://asc.fasb.org/topic&trid=49130388

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 13
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130556-203045

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130550-203045

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130558-203045

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 606
-SubTopic 10
-Section 50
-Paragraph 12
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126920106&loc=SL49130554-203045

+ Details

CONSOLIDATED STATEMENTS OF CHANGES IN MEMBERS' EQUITY AND TOTAL EQUITY (Parenthetical) $ in Thousands	12 Months Ended
	Dec. 31, 2021 USD ($)
IPO
Stock issuance cost, net	$ 11,394
Class A Units
Stock issuance cost, net	$ 1,614

Accounts Receivable (Tables)

12 Months Ended

Dec. 31, 2022

Receivables [Abstract]

Schedule of Accounts Receivable

Accounts receivable consisted of the following:


(in thousands)	December 31, 2022			December 31, 2021
Accounts receivable	$	59,780		$	44,303
Unbilled receivable		881			430
		60,661			44,733
Less: allowance for doubtful accounts		(1,862	)		(1,397	)
Accounts receivable, net	$	58,799		$	43,336

CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares	Dec. 31, 2022	Dec. 31, 2021
Common Class A
Common stock, par value	$ 0.001	$ 0.001
Common stock, shares authorized	600,000,000	600,000,000
Common stock, shares issued	105,138,273	97,030,095
Common stock, shares outstanding	105,138,273	97,030,095
Common Class B
Common stock, par value	$ 0.00001	$ 0.00001
Common stock, shares authorized	65,000,000	65,000,000
Common stock, shares issued	50,433,101	58,244,627
Common stock, shares outstanding	48,923,952	55,488,221

Income Taxes - Schedule Components of Income Before Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Income Tax Disclosure [Abstract]
Domestic	$ (34,617)	$ (56,597)	$ (49,610)
Foreign	(4,823)	(3,985)	(1,547)
Loss before income taxes	$ (39,440)	$ (60,582)	$ (51,157)

Commitments and Contingencies

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Commitments and Contingencies

14.

Commitments and Contingencies

The Company enters into purchase obligations in the normal course of doing business. The estimated annual minimum purchase commitments under those agreements were as follows for each of the years ending December 31:


(in thousands)
2023	$	11,032
2024		10,237
2025		6,491
	$	27,760

Derivative Instruments and Hedging Activities (Tables)

12 Months Ended

Dec. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Summary of Fair Values of the Interest Rate Swap

The fair values of the interest rate swaps and their respective locations in our consolidated balance sheets at December 31, 2022 were as follows:


(in thousands)
Description	Balance Sheet Location	December 31, 2022
Short-term derivative asset	Prepaid expenses and other current assets	$	3,716
Long-term derivative asset	Other assets		2,834

Description of Business

12 Months Ended

Dec. 31, 2022

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Business

Definitive Healthcare Corp. (together with its subsidiaries, “Definitive Healthcare” or the “Company”), through its operating subsidiary, Definitive OpCo, provides comprehensive and up-to-date hospital and healthcare-related information and insight across the entire healthcare continuum via a multi-tenant database platform which combines proprietary and public sources to deliver insights. Unless otherwise stated or the context otherwise indicates, references to “we”, “us”, “our”, “Definitive Healthcare”, and the “Company” refer (1) prior to the consummation of the Reorganization Transactions, to Definitive OpCo and its consolidated subsidiaries, and (2) after consummation of the Reorganization Transactions, to Definitive Healthcare Corp. and its consolidated subsidiaries.

Organization

Definitive Healthcare LLC, a subsidiary of Definitive Healthcare Holdings, LLC (“Definitive Holdco”), was founded in 2011 for the purpose of providing healthcare commercial intelligence that enables all companies that compete within or sell into the healthcare ecosystem to be more successful. AIDH TopCo, LLC (“Definitive OpCo”) is a Delaware limited liability company that was formed by investment funds affiliated with Advent International for the purposes of acquiring Definitive HoldCo. In July 2019, Definitive OpCo acquired a majority of the issued and outstanding units of Definitive HoldCo.

In May 2021, Definitive Healthcare Corp. was formed as a Delaware corporation for the purposes of facilitating an IPO and other related transactions in order to carry on the business of Definitive OpCo. Following consummation of the Reorganization Transactions, Definitive OpCo became a subsidiary of Definitive Healthcare Corp.

The Company is headquartered in Framingham, Massachusetts.

Initial Public Offering

On September 17, 2021, Definitive Healthcare completed its initial public offering (“IPO”), in which it sold 17,888,888 shares of Class A Common Stock (including shares issued pursuant to the exercise in full of the underwriters’ option to purchase additional shares) at a public offering price of $27.00 per share for net proceeds of $452.8 million, after deducting underwriters’ discounts and commissions (but excluding other offering expenses and reimbursements).

Definitive Healthcare Corp. used net proceeds from the IPO to (i) acquire 14,222,222 newly issued LLC Units from Definitive OpCo; (ii) purchase 1,169,378 LLC Units from certain holders of LLC Units; and (iii) repurchase 2,497,288 shares of Class A Common Stock received by the former shareholders of certain Blocker Companies (as defined below). Definitive OpCo used proceeds from the IPO to pay fees and expenses of approximately $11.4 million incurred in connection with the IPO and the Reorganization Transactions and to repay $199.6 million, inclusive of accrued interest expense, of the outstanding borrowings under our 2019 Credit Agreement, with the remaining proceeds intended to be used for general corporate purposes.

Reorganization Transactions

In connection with the IPO, the Company completed the following transactions (the “Reorganization Transactions”). Definitive OpCo entered into an amended and restated limited liability company agreement (the “Amended LLC Agreement”) pursuant to which members of Definitive OpCo prior to the IPO who continued to hold LLC Units following the consummation of the Reorganization Transactions acquired the right to require Definitive OpCo to redeem all or a portion of their LLC Units for newly issued shares of Class A Common Stock on a one-for-one basis. Until redeemed or exchanged, each LLC Unit is paired with one share of Definitive Healthcare Corp. Class B Common Stock. The total shares of Class B Common Stock outstanding is equal to the number of vested LLC Units outstanding, excluding LLC Units held by the Company. Unvested LLC Units are paired with Class B Common Stock, which are issued but do not have voting rights and are deemed not outstanding until the corresponding LLC Units have vested. Certain entities treated as corporations for U.S. federal income tax purposes that held LLC Units (individually, a “Blocker Company” and collectively, the “Blocker Companies”) each merged with a merger subsidiary of Definitive Healthcare Corp., and subsequently merged into Definitive Healthcare Corp. (the “Mergers”). The former shareholders of the Blocker Companies collectively received a number of shares of Class A Common Stock in the Mergers equal to the number of LLC Units held by the Blocker Companies prior to the Mergers.

Following the Reorganization Transactions, Definitive Healthcare Corp. became a holding company, with its sole material asset being a controlling equity interest in Definitive OpCo. Definitive Healthcare Corp. operates and controls all of the business and affairs of Definitive OpCo, and through Definitive OpCo and its subsidiaries, conducts its business. Accordingly, Definitive Healthcare Corp. consolidates the financial results of Definitive OpCo, and reports the noncontrolling interests of unexchanged LLC Unit holders on its consolidated financial statements.

In connection with the Reorganization Transactions and the IPO, Definitive Healthcare Corp entered into a tax receivable agreement. See Note 19. Income Taxes.

Follow-On Offering

On November 22, 2021, Definitive Healthcare Corp. completed a follow-on offering, in which it sold 11,000,000 shares of Class A Common Stock at a public offering price of $36.00 per share for net proceeds of $382.1 million, after deducting underwriters’ discounts and commissions (but excluding other offering expenses and reimbursements).

Definitive Healthcare Corp. used net proceeds from the follow-on offering to (i) acquire 7,000,000 newly issued LLC Units from Definitive OpCo; (ii) purchase 1,766,762 LLC Units from certain holders of LLC Units; and (iii) repurchase 2,233,238 shares of Class A Common Stock received by the former shareholders of certain Blocker Companies. Definitive OpCo used net proceeds from the follow-on offering to pay fees and expenses of approximately $1.6 million incurred in connection with the follow-on offering, with the remaining proceeds intended to be used for general corporate purposes.

Segment and Geographic Data (Tables)

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Schedule of Revenue by Geographic Areas

Revenues by geographic area presented based upon the location of the customer are as follows:


	For the Year Ended December 31,
(in thousands)	2022		2021		2020
United States	$	211,727	$	158,727	$	117,755
Rest of world		10,926		7,427		562
Total revenues	$	222,653	$	166,154	$	118,317

Schedule of Long-Lived Assets by Geographic Areas

Long-lived assets by geographical region are based on the location of the legal entity that owns the assets. Long-lived assets by geographic area presented based upon the location of the assets are as follows:


(in thousands)	December 31, 2022		December 31, 2021
United States	$	3,911	$	4,705
Rest of world		553		364
Total long-lived assets	$	4,464	$	5,069

Document and Entity Information - USD ($)
$ in Millions

12 Months Ended

Dec. 31, 2022

Feb. 23, 2023

Jun. 30, 2022

Cover [Abstract]

Document Type

10-K

Amendment Flag

false

Document Period End Date

Dec. 31, 2022

Document Fiscal Year Focus

2022

Document Fiscal Period Focus

Entity Registrant Name

Definitive Healthcare Corp.

Entity Voluntary Filers

Entity Central Index Key

0001861795

Entity Tax Identification Number

86-3988281

Current Fiscal Year End Date

--12-31

Entity Current Reporting Status

Yes

Entity Filer Category

Non-accelerated Filer

Entity File Number

001-40815

Entity Shell Company

false

Entity Well-known Seasoned Issuer

Entity Emerging Growth Company

false

Entity Small Business

false

Entity Interactive Data Current

Yes

Entity Incorporation State Country Code

Entity Address, Address Line One

492 Old Connecticut Path, Suite 401

Entity Address, City or Town

Framingham

Entity Address, State or Province

Entity Address Postal Zip Code

01701

508

720-4224

Class A Common Stock, $0.001 par value

Security Exchange Name

NASDAQ

Document Annual Report

true

Document Transition Report

false

Entity Common Stock, Shares Outstanding

107,598,147

Entity Public Float

$ 810.7

Documents Incorporated by Reference

Portions of the registrant’s proxy statement for the 2023 annual meeting of stockholders to be filed pursuant to Regulation 14A within 120 days after the registrant’s fiscal year ended December 31, 2022, are incorporated by reference in Part III of this Form 10-K.


Auditor Firm Id: PCAOB No. 34	Auditor Name: Deloitte & Touche LLP	Auditor Location: Boston, MA

Auditor Name

Deloitte & Touche LLP

Auditor Location

Boston, MA

Auditor Firm ID

Condensed Income Statement (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Gross profit	$ 180,028	$ 125,465	$ 87,849
Sales and marketing	89,585	56,387	34,332
Total operating expenses	221,291	150,446	102,294
Loss from operations	(41,263)	(24,981)	(14,445)
Net loss attributable to Definitive Healthcare Corp.	$ (6,037)	$ (17,677)	$ 0

- Definition

Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 9: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 18: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03.1,2)
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

Income Taxes - Schedule of Components of Income Tax Provision (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Current income taxes:
U.S. Federal	$ 82	$ (7)	$ 10
U.S. state and local	26	0	1
Total current income taxes	108	(7)	11
Deferred income taxes:
U.S. federal	(1,024)	369	58
U.S. state and local	(16,040)	313	(7)
Foreign	(229)	0	0
Total deferred income taxes	(17,293)	682	51
Income tax (benefit) expense	$ (17,185)	$ 675	$ 62

CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (22,255)	$ (61,257)	$ (51,157)
Other comprehensive (loss) income:
Foreign currency translation adjustments	(832)	193	(131)
Unrealized loss on available-for-sale securities	(224)	0	0
Unrealized gain on interest rate hedging instruments	6,550	0	0
Comprehensive loss	(16,761)	(61,064)	(51,288)
Less: Comprehensive loss attributable to Definitive OpCo prior to the Reorganization Transactions	0	(33,201)	(51,288)
Less: Comprehensive loss attributable to noncontrolling interests	(14,330)	(10,237)	0
Comprehensive loss attributable to Definitive Healthcare Corp.	$ (2,431)	$ (17,626)	$ 0

Commitments and Contingencies (Tables)

12 Months Ended

Dec. 31, 2022

Commitments and Contingencies Disclosure [Abstract]

Schedule of Estimated Annual Minimum Purchase Commitments


(in thousands)
2023	$	11,032
2024		10,237
2025		6,491
	$	27,760

Stockholders' Equity and Members' Equity

12 Months Ended

Dec. 31, 2022

Members' Equity [Abstract]

Stockholders' Equity and Members' Equity

16.

Stockholders' Equity and Members' Equity

The Company has Class A Common Stock, Class B Common Stock and Preferred Stock. Holders of outstanding shares of Class A and Class B Common Stock vote as a single class on all matters on which stockholders are entitled to vote generally, except as otherwise required by law. Class B Common Stock issued to holders of Definitive OpCo Units (directly or indirectly through AIDH Management Holdings, LLC) that are unvested shall have no vote per share until such time as such Units have vested.

Class A Common Stockholders are entitled to receive dividends, if declared by our board of directors out of legally available funds. Upon our liquidation, dissolution or winding up and after payment in full of all amounts required to be paid to creditors and to the holders of Preferred Stock having liquidation preferences, if any, the holders of shares of our Class A Common Stock will be entitled to receive pro rata our remaining assets available for distribution.

Class B Common Stockholders are not entitled to economic interests in Definitive Healthcare Corp. and do not have any right to receive dividends or to receive a distribution upon a liquidation or winding up of Definitive Healthcare Corp.

Shares of Preferred Stock have not been issued at December 31, 2022. The board of directors may authorize one or more series of Preferred Stock (including convertible Preferred Stock) and will determine, with respect to any series of Preferred Stock, the voting rights, preferences, participation, or other special right and limitations.

Under the Amended Definitive OpCo LLC Agreement, the holders of LLC Units other than Definitive Healthcare Corp. (“LLC Members”) have the right to redeem or exchange all or a portion of their LLC Units for newly issued shares of Class A Common Stock, which may consist of unregistered shares, on a one-for-one basis. Shares of Class B Common Stock and their corresponding LLC Units will be canceled on a one-for-one basis once an exchange has been completed.

Upon formation of Definitive OpCo in conjunction with the Advent Acquisition in July 2019, two classes of LLC units were established: Class A Units (“Class A Units”) and Class B Units (“Class B Units”), collectively “the Units”.

In 2020, the Company contributed $25.4 million worth of its Class A Units to partially fund the acquisition of Monocl that occurred in October 2020 (see Note 3. Acquisitions and Investments). The Company also received an additional $6.4 million contribution for buy-in of Class A Units from certain members.

The table below provides a summary of the number of Units authorized, issued and outstanding as of December 31, 2020:


	December 31, 2020
Class A Units:
Authorized, issued and outstanding Class A Units		130,245,990
Class B Units:
Authorized Class B Units		8,088,877
Issued Class B Units		3,720,063
Outstanding Class B Units (vested Class B Units)		474,920

In 2021, the Company issued 363,516 new Class A Units worth $5.8 million, consisting of a capital contribution of $5.5 million and equity-based compensation expense of $0.3 million. In connection with the Reorganization Transactions and the IPO in September 2021, Class A Units held directly by employees of the Company or indirectly through Definitive OpCo were exchanged on a one-for-one basis for Definitive OpCo LLC Units.

Refer to Note 17. Equity-Based Compensation for more detail on Class B Units.

Noncontrolling Interest

Definitive Healthcare Corp. operates and controls all of the business and affairs of Definitive OpCo, and through Definitive OpCo and its subsidiaries, conducts its business. Accordingly, Definitive Healthcare Corp. consolidates the financial results of Definitive OpCo, and reports the noncontrolling interests of its consolidated subsidiaries on its consolidated financial statements based on the Definitive OpCo Units held by LLC Members. Changes in Definitive Healthcare Corp.'s ownership interest in its consolidated subsidiaries are accounted for as equity transactions. As such, future redemptions or direct exchanges of OpCo Units by LLC Members will result in a change in ownership and reduce or increase the amount recorded as Noncontrolling interests and increase or decrease Additional paid-in capital in the Company’s consolidated balance sheets.

During the year ended December 31, 2022, 7,624,654 Definitive OpCo Units held by LLC Members were exchanged for shares of Class A Common Stock of Definitive Healthcare Corp. pursuant to the terms of the Amended LLC Agreement. In addition, 483,524 restricted stock units vested, net of shares withheld for taxes, resulting in the issuance of 483,524 shares of Class A Common Stock of Definitive Healthcare Corp., for which Definitive OpCo Units were issued on a one-for-one basis pursuant to the Definitive OpCo second amended and restated limited liability company agreement entered into in connection with the IPO.

As of December 31, 2022 and 2021, Definitive Healthcare Corp. held 105,133,670 and 97,030,095 units in Definitive OpCo, respectively, resulting in ownership interests as of December 31, 2022 and 2021 of 68.2% and 63.6%, respectively, and noncontrolling interests of 31.8% and 36.4%, respectively.

Summary of Significant Accounting Policies - Schedule of Estimated Useful Lives of the Assets (Details)	12 Months Ended
	Dec. 31, 2022
Data [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	3 years
Minimum [Member] \| Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	14 years
Minimum [Member] \| Technology [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	6 years
Minimum [Member] \| Trademarks and Trade Names [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	5 years
Maximum [Member] \| Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	20 years
Maximum [Member] \| Technology [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	8 years
Maximum [Member] \| Trademarks and Trade Names [Member]
Finite Lived Intangible Assets [Line Items]
Customer relationships	19 years

Leases - Supplemental cash flow information related to leases (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Cash Paid For Amounts Included In The Measurement Of Lease Liabilities Abstract
Operating cash flows	$ 3,145
Right Of Use Assets Obtained In Exchange For New Lease Liabilities Abstract
Capitalized operating leases	$ 982

Equity-based Compensation - Schedule of Company's Unvested Time-Based and Performance-Based Unit Activity (Detail) - $ / shares	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Time-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unvested at beginning of year	1,935,899	0
Granted	2,457,991	1,965,477
Vested	(716,776)	0
Forfeited	(238,727)	(29,578)
Unvested at end of year	3,438,387	1,935,899
Non vested weighted average grant date fair value	$ 32.59	$ 0
Non vested weighted average grant date fair value, Granted	20.27	32.50
Non vested weighted average grant date fair value, vested	29.86	0
Non vested weighted average grant date fair value, forfeited	25.51	27.00
Non vested weighted average grant date fair value	$ 24.82	$ 32.59
Performance-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unvested at beginning of year	164,351	0
Granted	125,000	164,351
Vested	0	0
Forfeited	(164,351)	0
Unvested at end of year	125,000	164,351
Non vested weighted average grant date fair value	$ 27.00	$ 0
Non vested weighted average grant date fair value, Granted	54.25	27.00
Non vested weighted average grant date fair value, vested	0	0
Non vested weighted average grant date fair value, forfeited	27.00	0
Non vested weighted average grant date fair value	$ 54.25	$ 27.00
Time Based Unit
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Unvested at beginning of year	2,756,406
Vested	(1,060,385)
Forfeited	(186,872)
Unvested at end of year	1,509,149	2,756,406
Non vested weighted average grant date fair value	$ 2.02
Non vested weighted average grant date fair value, vested	2.03
Non vested weighted average grant date fair value, forfeited	2.03
Non vested weighted average grant date fair value	$ 2.03	$ 2.02

Acquisitions and Investments - Summary of Transaction Transferred (Details) - USD ($) $ in Thousands			12 Months Ended
	Feb. 18, 2022	Oct. 27, 2020	Dec. 31, 2022	Dec. 31, 2021
Business Acquisition [Line Items]
Initial cash investment in December 2021	$ 40,000			$ 40,000
Cash consideration	58,600	$ 18,300	$ 58,645
Working capital adjustments	200		(202)
Contingent consideration	$ 5,000	15,000	1,000
Equity issuance		$ 25,400
Purchase price			99,443
Monocl
Business Acquisition [Line Items]
Cash consideration			18,307
Contingent consideration			2,600
Equity issuance			25,439
Purchase price			$ 46,346

Commitments and Contingencies - Schedule of Estimated Annual Minimum Purchase Commitments (Details) $ in Thousands	Dec. 31, 2022 USD ($)
Commitments and Contingencies Disclosure [Abstract]
2023	$ 11,032
2024	10,237
2025	6,491
Purchase Obligation, Total	$ 27,760

Goodwill and Intangible Assets - Schedule of Changes in the Carrying Amount of Goodwill (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)
Finite Lived Intangible Assets [Line Items]
Beginning balance	$ 1,261,444
Ending balance	$ 1,323,102

- Definition

Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.

+ References + Details

Revenue - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Disaggregation Of Revenue [Line Items]
Revenue	$ 222,653	$ 166,154	$ 118,317
Subscription Services [Member]
Disaggregation Of Revenue [Line Items]
Revenue	217,024	164,564	117,080
Professional Services [Member]
Disaggregation Of Revenue [Line Items]
Revenue	$ 5,629	$ 1,590	$ 1,237

- Definition

Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 22: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(1))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

Acquisitions and Investments - Additional Information (Details)				12 Months Ended
	Feb. 18, 2022 USD ($)	Dec. 22, 2021 USD ($)	Oct. 27, 2020 USD ($)	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)
Investment		$ 40,000,000.0
Purchase option ownership percentage		65.00%
Purchase of Ownership percentage	0.65
Cash consideration paid at closing	$ 58,600,000		$ 18,300,000	$ 58,645,000
Purchase price				99,443,000
Working capital adjustments	200,000			(202,000)
Contingent consideration	5,000,000.0		15,000,000.0	1,000,000
Initial value of contingent consideration				1,000,000.0
Fair value of the contingent consideration	1,000,000.0		2,600,000		$ 7,500,000	$ 5,200,000
Initial cash investment in December 2021	40,000,000.0				40,000,000
Escrow deposit	10,000,000.0
Purchase price consideration	65,000,000.0
Equity issuance			25,400,000
Revenue				222,653,000	166,154,000	118,317,000
Net Income Loss				(6,037,000)	(17,677,000)	0
Interest expense				700,000	200,000
Business combination, contingent consideration, liability				$ 2,300,000
Monocl Holding Company [Member]
Fair value of the contingent consideration			2,600,000
Business combination,deferred revenue			$ 2,900,000
Weighted average amortization period			14 years
Business combination, Acquisition related costs			$ 400,000			400,000
Revenue						1,200,000
Net Income Loss						1,600,000
Adjustments to amortization expense						800,000
Interest expense						1,000,000.0
Minimum [Member] \| Monocl Holding Company [Member]
Purchase price			46,300,000
Maximum [Member] \| Monocl Holding Company [Member]
Purchase price			60,000,000.0
Developed software
Other assets	6,100,000
Analytical Wizards Acquisition [Member]
Purchase price	99,400,000
Trademarks Member
Other assets			1,400,000
Trademarks Member \| Monocl Holding Company [Member]
Other assets			$ 1,400,000
Customer relationships			19 years
Trade Names [Member]
Other assets	500,000
Trade Names [Member] \| Monocl Holding Company [Member]
Weighted average amortization period			17 years
Customer Relationships [Member]
Other assets	39,400,000		$ 11,900,000
Customer Relationships [Member] \| Monocl Holding Company [Member]
Other assets			$ 11,900,000
Weighted average amortization period			15 years
Customer Relationships [Member] \| Minimum [Member]
Customer relationships				14 years
Customer Relationships [Member] \| Maximum [Member]
Customer relationships				20 years
Data [Member]
Other assets			$ 3,000,000.0
Data [Member] \| Monocl Holding Company [Member]
Other assets			$ 3,000,000.0
Weighted average amortization period			3 years
Technology [Member]
Other assets			$ 2,600
Technology [Member] \| Monocl Holding Company [Member]
Other assets			$ 2,600,000
Weighted average amortization period			8 years
Goodwill [Member]
Other assets	61,700		$ 28,300,000
Series of Individually Immaterial Business Acquisitions Member
Potential payouts range, Low	0				0	0
Potential payouts range, High	5,000,000.0				10,000,000	5,000,000.0
Series of Individually Immaterial Business Acquisitions Member \| Minimum [Member]
Annual recurring revenue					12,000,000.0	8,500,000
Series of Individually Immaterial Business Acquisitions Member \| Maximum [Member]
Annual recurring revenue					$ 16,000,000.0	$ 9,500,000
AW acquisition
Fair value of the contingent consideration	$ 1,000,000.0
Weighted average amortization period	20 years
Business combination, Acquisition related costs				$ 1,300,000
Date of acquisition				Feb. 18, 2022
AW acquisition \| Developed software
Other assets	$ 6,100,000
Weighted average amortization period	6 years
AW acquisition \| Trademarks Member
Other assets	$ 500,000
Customer relationships	5 years
AW acquisition \| Trade Names [Member]
Weighted average amortization period	5 years
AW acquisition \| Customer Relationships [Member]
Other assets	$ 39,400,000
Weighted average amortization period	20 years
Call Option [Member]
Stock issued during period value stock options exercised		$ 65,000,000.0
Option indexed to issuers equity settlement alternatives cash at fair value		$ 7,300,000
Series B Preferred Stock [Member]
Preferred stock convertible conversion ratio		0.35
Option indexed to issuers equity settlement alternatives cash at fair value		$ 32,700,000
Series B Preferred Stock [Member] \| Purchase Option [Member]
Option indexed to issuers equity settlement alternatives cash at fair value		$ 40,000,000.0

Accrued Expenses and Other Current Liabilities (Tables)

12 Months Ended

Dec. 31, 2022

Accounts Payable and Accrued Liabilities, Current [Abstract]

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities consisted of the following:


(in thousands)	December 31, 2022		December 31, 2021
Payroll and payroll-related	$	11,961	$	10,311
Contingent consideration, current		—		7,500
Sales, franchise and other taxes		3,631		1,876
Other		3,156		2,971
Accrued expenses and other current liabilities	$	18,748	$	22,658

Revenue (Tables)

12 Months Ended

Dec. 31, 2022

Revenue from Contract with Customer [Abstract]

Schedule of Disaggregation of Revenue

The following table represents a disaggregation of revenue from arrangements with customers for the years ended December 31, 2022, 2021 and 2020.


	Year Ended December 31,
(in thousands)	2022		2021		2020
Subscription services	$	217,024	$	164,564	$	117,080
Professional services		5,629		1,590		1,237
Total revenue	$	222,653	$	166,154	$	118,317

Summary of Receivables, Deferred Contract Costs and Contract Liabilities from Contract with Customers

The opening and closing balances of the Company’s receivables, deferred contract costs and contract liabilities from contracts with customers are as follows:


(in thousands)	December 31, 2022		December 31, 2021
Accounts receivable, net	$	58,799	$	43,336
Deferred contract costs		10,387		6,880
Long-term deferred contract costs		14,596		11,667
Deferred revenues		99,928		84,023

Deferred Contract Costs

A summary of the activity impacting the deferred contract costs during the years ended December 31, 2022 and 2021 is presented below:


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	18,547		$	8,899
Costs amortized		(8,816	)		(4,792	)
Additional amounts deferred		15,252			14,440
Balance at end of year		24,983			18,547
Classified as:
Current		10,387			6,880
Non-current		14,596			11,667
Total deferred contract costs (deferred commissions)	$	24,983		$	18,547

Summary of Deferred Revenue Balances

A summary of the activity impacting deferred revenue balances during the years ended December 31, 2022 and 2021

is presented below:


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	84,023		$	61,200
Revenue recognized		(222,653	)		(166,154	)
Additional amounts deferred		238,558			188,977
Balance at end of year	$	99,928		$	84,023

Summary of Remaining Performance Obligation

The remaining performance obligations consisted of the following:


(in thousands)	December 31, 2022		December 31, 2021
Current	$	183,527	$	155,134
Non-current		93,464		95,354
Total	$	276,991	$	250,488

Short-term Investments

12 Months Ended

Dec. 31, 2022

Investments, Debt and Equity Securities [Abstract]

Short-term Investments

Short-term investments classified as available-for-sale consisted of the following:


	December 31, 2022
(in thousands)	Amortized Cost		Gross Unrealized Gains		Gross Unrealized Losses			Fair Value
Short-term investments:
US treasuries	$	59,849	$	3	$	(129	)	$	59,723
Agency bonds		6,450		4		(2	)		6,452
Commercial paper		95,831		29		(123	)		95,737
Certificates of deposit		23,034		17		(24	)		23,027
Total short-term investments	$	185,164	$	53	$	(278	)	$	184,939

Acquisitions and Investments - Schedule of Business Acquisition, Pro Forma Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Business Acquisition [Line Items]
Revenue	$ 224,130	$ 176,169
Net loss	$ (22,595)	$ (61,125)
2020 Acquisitions [Member]
Business Acquisition [Line Items]
Revenue			$ 122,333
Net loss			$ (58,350)

Long-Term Debt - Additional Information (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Debt Instrument [Line Items]
Frequency of payment		The 2021 Term Loan is subject to annual amortization of principal, payable in equal quarterly installments on the last day of each fiscal quarter, commencing on December 31, 2021 (the “Initial Amortization Date”), equal to approximately 2.5% per annum of the principal amount of the term loans in the first year and second year after the Initial Amortization Date and approximately 5.0% per annum of the principal amount of the term loans in the third year, fourth year and fifth year after the Initial Amortization Date.
Financing costs		$ 3,500
Interest expense		700	$ 200
Proceeds from revolving credit facility		0	0	$ 25,000
Repayments of lines of credit		0	0	$ 25,000
2021 Term Loan [Member]
Debt Instrument [Line Items]
Outstanding principal balance		266,406	273,282
Unamortized debt issuance costs / financing costs		2,047	2,599
Line Of credit	$ 275,000
Balloon payment		220,000
Financing costs		$ 2,800
2021 Revolving line of Credit [Member]
Debt Instrument [Line Items]
Interest rate		6.17%
Unamortized debt issuance costs / financing costs		$ 600	$ 700
Line Of credit	$ 75,000
Maturity date	Sep. 17, 2026
Financing costs		$ 800
2021 Revolving line of Credit [Member] \| Minimum [Member]
Debt Instrument [Line Items]
Unused commitment fee percentage		0.25%
2021 Revolving line of Credit [Member] \| Maximum [Member]
Debt Instrument [Line Items]
Unused commitment fee percentage		0.30%

Equity-based Compensation - Summary of Equity Based Compensation Expense Recognized (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 36,434	$ 9,957	$ 1,747
Cost of revenue
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	942	277	62
Sales and marketing
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	13,508	1,930	473
Product development
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	7,805	1,070	356
General and administrative
Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 14,179	$ 6,680	$ 856

Segment and Geographic Data - Schedule of Revenue by Geographic Areas (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Entity Wide Revenue Major Customer [Line Items]
Revenue	$ 222,653	$ 166,154	$ 118,317
United States [Member]
Entity Wide Revenue Major Customer [Line Items]
Revenue	211,727	158,727	117,755
Rest of world [Member]
Entity Wide Revenue Major Customer [Line Items]
Revenue	$ 10,926	$ 7,427	$ 562

- Definition

+ References

+ Details

Leases - Schedule of operating lease liabilities (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Leases [Abstract]
2023	$ 1,960	$ 3,120
2024	2,344	1,895
2025	2,143	2,282
2026	2,071	2,174
2027	2,112	2,165
Thereafter	2,360	4,805
Total undiscounted future minimum lease payments	12,990	$ 16,441
Imputed interest	1,500
Operating lease liability	$ 11,490

Loss Per Share - Schedule of Net Loss Per Share, Basic and Diluted (Details) - USD ($)
$ / shares in Units, $ in Thousands

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Net loss

$ (22,255)

$ (61,257)

$ (51,157)

Less: Net loss attributable to Definitive OpCo before Reorganization Transactions

(33,343)

(51,157)

Less: Net loss attributable to noncontrolling interests

(16,218)

(10,237)

Net loss attributable to Definitive Healthcare Corp.

(6,037)

(17,677)

Basic net loss per share attributable to common stockholders [Abstract]

Allocation of net loss attributable to Definitive Healthcare Corp.

$ (6,037)

$ (17,677)

$ 0

Weighted average number of shares of Class A outstanding

^[1]

101,114,105

91,916,151

Net loss per share, basic

$ (0.06)

$ (0.19)

Net loss per share, diluted

$ (0.06)

$ (0.19)

Common Class A

Net loss

$ (22,255)

$ (61,257)

Less: Net loss attributable to Definitive OpCo before Reorganization Transactions

(33,343)

Less: Net loss attributable to noncontrolling interests

(16,218)

(10,237)

Net loss attributable to Definitive Healthcare Corp.

(6,037)

(17,677)

Basic net loss per share attributable to common stockholders [Abstract]

Allocation of net loss attributable to Definitive Healthcare Corp.

$ (6,037)

$ (17,677)

Weighted average number of shares of Class A outstanding

101,114,105

91,916,151

Net loss per share, basic

$ (0.06)

$ (0.19)

Net loss per share, diluted

$ (0.06)

$ (0.19)

[1]

Basic and diluted net loss per share of Class A Common Stock is applicable only for the year ended December 31, 2022 and for the period from September 15, 2021 through December 31, 2021, which is the period following the IPO and related Reorganization Transactions. See Note 20 for the number of shares used in the computation of net loss per share of Class A Common Stock and the basis for the computation of net loss per share.

- Definition

The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 10
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 9: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

+ Details

- Definition

The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.

+ References

Reference 1: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 52
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 7
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 55
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(27))
-URI https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(23))
-URI https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (e)(4)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(25))
-URI https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227

+ Details

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (a)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(i))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 815
-SubTopic 40
-Section 65
-Paragraph 1
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 45
-Paragraph 19
-URI https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 235
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-05(b)(2))
-URI https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884

Reference 23: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 24: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580

Reference 25: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iv))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 26: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(iii)(A))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 27: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(5))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 28: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1B
-Subparagraph (SX 210.13-02(a)(4)(iii)(B))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756

Reference 29: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 10
-Section S99
-Paragraph 1A
-Subparagraph (SX 210.13-01(a)(4)(ii))
-URI https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756

Reference 30: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 50
-Paragraph 1A
-Subparagraph (c)(1)
-URI https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684

Reference 31: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4J
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686

Reference 32: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 810
-SubTopic 10
-Section 55
-Paragraph 4K
-URI https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686

Reference 33: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794

+ Details

Fair Value Measurements - Additional Information (Details) - USD ($) $ in Millions	3 Months Ended
	Jun. 30, 2022	Dec. 31, 2022
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Business combination, contingent consideration, liability		$ 2.3
Office Relocation [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Asset Impairment Charges	$ 1.0
Operating Lease Right Of Use Asset [Member] \| Office Relocation [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Asset Impairment Charges	0.9
Leasehold Improvements \| Office Relocation [Member]
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]
Asset Impairment Charges	$ 0.1

Segment and Geographic Data

12 Months Ended

Dec. 31, 2022

Segment Reporting [Abstract]

Segment and Geographic Data

21.

Segment and Geographic Data

The Company operates as one operating segment. Operating segments are defined as components of the Company for which separate financial information is available and evaluated regularly by the Company’s chief operating decision maker in deciding how to allocate resources and in assessing performance. The chief operating decision maker for the Company is the chief executive officer. The chief executive officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by type of service and geographic region, for purposes of allocating resources and evaluating financial performance.

Revenues by geographic area presented based upon the location of the customer are as follows:


	For the Year Ended December 31,
(in thousands)	2022		2021		2020
United States	$	211,727	$	158,727	$	117,755
Rest of world		10,926		7,427		562
Total revenues	$	222,653	$	166,154	$	118,317

For a summary of our revenue disaggregated by service, refer to Note 4. Revenue.


(in thousands)	December 31, 2022		December 31, 2021
United States	$	3,911	$	4,705
Rest of world		553		364
Total long-lived assets	$	4,464	$	5,069

- Definition

The entire disclosure for reporting segments including data and tables. Reportable segments include those that meet any of the following quantitative thresholds a) it's reported revenue, including sales to external customers and intersegment sales or transfers is 10 percent or more of the combined revenue, internal and external, of all operating segments b) the absolute amount of its reported profit or loss is 10 percent or more of the greater, in absolute amount of 1) the combined reported profit of all operating segments that did not report a loss or 2) the combined reported loss of all operating segments that did report a loss c) its assets are 10 percent or more of the combined assets of all operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 34
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8981-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 40
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (e)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 26
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8844-108599

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 41
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (d)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599

Reference 11: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 42
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599

Reference 12: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 15
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8657-108599

Reference 13: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 21
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8721-108599

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-URI https://asc.fasb.org/topic&trid=2134510

+ Details

Goodwill and Intangible Assets (Tables)

12 Months Ended

Dec. 31, 2022

Goodwill and Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets and Goodwill

The carrying amounts of goodwill and intangible assets, as of December 31, 2022 and 2021, consist of the following:


	December 31, 2022
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	409,430	$	(128,745	)	$	280,685
Developed technologies		56,965		(25,514	)		31,451
Tradenames		35,914		(7,150	)		28,764
Database		50,215		(40,393	)		9,822
Total finite-lived intangible assets		552,524		(201,802	)		350,722
Goodwill		1,323,102		—			1,323,102
Total goodwill and intangible assets	$	1,875,626	$	(201,802	)	$	1,673,824


	December 31, 2021
(in thousands)	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Finite-lived intangible assets:
Customer relationships	$	370,030	$	(92,942	)	$	277,088
Developed technologies		51,100		(17,475	)		33,625
Tradenames		35,500		(5,034	)		30,466
Database		43,080		(31,789	)		11,291
Total finite-lived intangible assets		499,710		(147,240	)		352,470
Goodwill		1,261,444		—			1,261,444
Total goodwill and Intangible assets	$	1,761,154	$	(147,240	)	$	1,613,914

Schedule of Future Amortization Expense

Estimated total intangible amortization expense during the next five years and thereafter is as follows:


(in thousands)
2023	$	49,833
2024		46,986
2025		42,420
2026		34,888
2027		28,559
Thereafter		148,036
Total	$	350,722

Summary of Significant Accounting Policies - Additional Information (Details) $ in Thousands	12 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Mar. 31, 2022 USD ($)
Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) [Line Items]
Percentage of net sales or account receivable	10	10	10
Allowance for Doubtful Accounts	$ 1,900	$ 1,400
Contract liabilities	99,928	84,023	$ 61,200
Other Deferred Costs, Net	2,000	2,600
Capitalized Contract, Impairment Cost	0	0	0
Advertising Expense	1,600	900	600
Capitalized Computer Software, Net	1,000	600	100
Impairment of goodwill	$ 0	0	$ 0
Operating lease term of contract	4 years
Operating lease right-of-use assets, net	$ 9,681	$ 0
Operating lease liability	$ 11,490
ASU 2016-02 [Member]
Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) [Line Items]
Operating lease term of contract	12 months
Operating lease right-of-use assets, net	$ 12,700
Operating lease liability	$ 14,000
Aw Acquisition [Member]
Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) [Line Items]
Contract liabilities				$ 3,400
Maximum [Member]
Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) [Line Items]
Term Of Subscription Contracts	3 years
Minimum [Member]
Disclosure - Summary of Significant Accounting Policies - Additional Information (Details) [Line Items]
Term Of Subscription Contracts	1 year

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows provided by operating activities:
Net loss	$ (22,255)	$ (61,257)	$ (51,157)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Depreciation and amortization	2,193	1,751	1,152
Amortization of intangible assets	54,711	58,196	58,429
Amortization of deferred contract costs	8,816	4,793	1,671
Equity-based compensation	36,434	9,957	1,747
Noncash paid in-kind interest expense	0	0	7,371
Amortization of debt issuance costs	702	1,698	2,061
Provision for doubtful accounts receivable	1,325	632	895
Loss in extinguishment of debt	0	9,843	0
Non-cash restructuring charges related to office leases	1,023	0	0
Tax receivable agreement remeasurement	(9,374)	0	0
Changes in fair value of contingent consideration	1,250	3,764	2,636
Deferred income taxes	(17,293)	682	0
Changes in operating assets and liabilities:
Accounts receivable	(13,222)	(10,726)	(8,294)
Prepaid expenses and other current assets	(127)	(3,729)	(709)
Deferred contract costs	(15,252)	(14,441)	(7,685)
Contingent consideration	(6,400)	0	0
Accounts payable, accrued expenses and other liabilities	358	1,088	2,996
Deferred revenue	12,690	22,961	12,104
Net cash provided by operating activities	35,579	25,212	23,217
Cash flows (used in) provided by investing activities:
Purchases of property, equipment and other assets	(8,326)	(6,731)	(1,395)
Purchases of short-term investments	(337,961)	0	0
Maturities of short-term investments	153,680	0	0
Cash paid for acquisitions and investments, net of cash acquired	(56,296)	(40,000)	(22,467)
Net cash used in investing activities	(248,903)	(46,731)	(23,862)
Cash flows (used in) provided by financing activities:
Proceeds from Term Loan	0	275,000	0
Proceeds from delayed draw term loan	0	0	18,000
Proceeds from revolving credit facility	0	0	25,000
Repayments of term loans and delayed draw term loan	(6,875)	(474,460)	(4,545)
Taxes paid related to net share settlement of equity awards	(4,116)	0	0
Repayments on revolving credit facility	0	0	(25,000)
Payment of contingent consideration	(1,100)	(1,500)	0
Payment of debt issuance costs	0	(3,511)	(225)
Proceeds from equity offering, net of underwriting discounts	0	834,952	0
Repurchase of outstanding equity / Definitive OpCo units	0	(231,772)	0
Payments of equity offering issuance costs	(1,734)	(11,709)	0
Members contributions	0	5,500	6,365
Members distributions	(12,871)	(8,128)	(2,940)
Net cash (used in) provided by financing activities	(26,696)	384,372	16,655
Net (decrease) increase in cash and cash equivalents	(240,020)	362,853	16,010
Effect of exchange rate changes on cash and cash equivalents	(544)	(129)	146
Cash and cash equivalents, beginning of year	387,498	24,774	8,618
Cash and cash equivalents, end of year	146,934	387,498	24,774
Supplemental cash flow disclosures:
Interest	10,443	29,569	25,958
Income taxes	0	13	0
Acquisitions
Net assets acquired, net of cash acquired	97,296	0	43,571
Initial cash investment in prior year	(40,000)	0	0
Capital contribution	0	0	(25,439)
Contingent consideration	(1,000)	0	(2,600)
Consideration paid to former members included in accrued expenses	0	0	6,935
Net cash paid for acquisitions	56,296	0	22,467
Supplemental disclosures of non-cash investing activities:
Capital expenditures included in accounts payable and accrued expenses and other current liabilities	1,166	654	3,389
Supplemental disclosures of non-cash financing activities:
Unpaid equity offering costs included in accrued expenses	$ 0	$ 1,299	$ 0

Equity-based Compensation - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Dec. 31, 2022	Sep. 30, 2021	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 36,434,000	$ 9,957,000	$ 1,747,000
Time-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 27,000,000.0	$ 4,400,000
Forfeited			238,727	29,578
Unrecognized expense related to unit-based compensation	$ 75,800,000		$ 75,800,000
Weighted-average period over which cost not yet recognized is expected to be recognized			2 years 8 months 12 days
Performance-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 1,700,000	$ 0
Forfeited			164,351	0
Unrecognized expense related to unit-based compensation	5,100,000		$ 5,100,000
Weighted-average period over which cost not yet recognized is expected to be recognized			2 years
Share based compensation accelerated vesting number of shares			0
Share based compensation plan modification incremental compensation cost			$ 0
Performance-Based RSUs \| Maximum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting percentage			300.00%
Performance-Based RSUs \| Minimum [Member]
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Award vesting percentage			0.00%
Time Based Unit
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Stock-based compensation expense			$ 7,700,000	$ 3,400,000
Forfeited			186,872
Unrecognized expense related to unit-based compensation	$ 8,200,000		$ 8,200,000
Weighted-average period over which cost not yet recognized is expected to be recognized			1 year 8 months 12 days
2021 Equity Incentive Plan \| Common Class A
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized	4,942,128		4,942,128
IPO \| 2019 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Issue Price Per Share	$ 27.00		$ 27.00
Executive Officer
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation plan modification incremental compensation cost		$ 1,900,000
Management Level Employees \| Time-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation accelerated vesting number of shares	6,772
Share based compensation plan modification incremental compensation cost	$ 100,000
Share based compensation number of shares forfeitured in period			21,877
Management Level Employees \| Performance-Based RSUs
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation number of shares forfeitured in period			13,889
Management Level Employees \| 2019 Equity Incentive Plan
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]
Share based compensation accelerated vesting number of shares	126,350
Share based compensation plan modification incremental compensation cost	$ 1,800,000
Share based compensation number of shares forfeitured in period			81,857

Leases - Schedule of lease term and discount rate (Details)	Dec. 31, 2022
Weighted-Average Remaining Lease Term Abstract
Capitalized operating leases	5 years 9 months 10 days
Weighted-Average Discount Rate Abstract
Capitalized operating leases	4.20%

Income Taxes - Additional Information (Details) - USD ($)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Operating Loss Carryforwards [Line Items]
Valuation Allowance	$ 187,807,000	$ 164,394,000	$ 1,430,000
Unrecognized tax benefits	$ 0	$ 0
Tax receivable agreement realized tax benefits payable to related parties percent	85.00%
Tax Receivable Agreement Benefit percentage	15.00%
TRA liability increased amount	$ 2,800,000
Tax Receivable Agreement Liability Increasing Adjustment	12,200,000
TRA liability decreasing amount	9,400,000
additional liability on net operating loss tax adjustment	109,100,000
Total liability on net operating loss taxadjustment	265,400,000
Swedish Monocl [Member]
Operating Loss Carryforwards [Line Items]
Tax receivable agreement liability	156,300,000
US Federal [Member] \| 2040 through 2042 [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	192,100,000
Tax credit carryforward, amount	700,000
US State [Member] \| 2022 through indefinite [Member]
Operating Loss Carryforwards [Line Items]
Tax credit carryforward, amount	147,200,000
US State [Member] \| 2037 through indefinite [Member]
Operating Loss Carryforwards [Line Items]
Tax credit carryforward, amount	300,000
Foreign [Member] \| 2030 through indefinite [Member]
Operating Loss Carryforwards [Line Items]
Operating loss carryforwards	$ 14,000,000.0

Income Taxes - Schedule of Reconciliation of the Federal Income Tax Rate To Income Tax Rate (Details)	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Effective Income Tax Rate Reconciliation, Percent [Abstract]
Expected U.S. federal income taxes at statutory rate	21.00%	21.00%	21.00%
Change in valuation allowance	(41.21%)	(13.94%)	0.60%
State and local income taxes, net of federal benefit	40.53%	(0.51%)	(0.14%)
Outside basis adjustment	19.95%	8.90%	0.00%
Partnership income, not subject to taxation	(8.64%)	(19.44%)	(27.55%)
Return to provision	6.05%	3.67%	0.46%
TRA remeasurement	4.99%	0.00%	0.00%
Research and development credits	1.42%	0.17%	0.00%
Foreign rate differential	1.35%	(0.02%)	(0.01%)
Stock compensation	(1.23%)	0.00%	0.00%
Other	(0.64%)	(0.94%)	(5.52%)
Effective income tax rate	43.57%	(1.11%)	(0.12%)

Loss Per Share

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Loss Per Share

20.

Loss Per Share

Basic net loss per share of Class A Common Stock is computed by dividing net loss attributable to Definitive Healthcare Corp. by the weighted-average number of shares of Class A Common Stock outstanding during the period, excluding unvested equity awards and subsidiary member units not exchanged. Diluted earnings per share of Class A Common Stock is calculated by dividing net income attributable to Definitive Healthcare Corp., adjusted for the assumed exchange of all potentially dilutive securities by the weighted-average number of shares of Class A Common Stock outstanding.

The following table sets forth the reconciliation of the numerator and denominator used to compute basic and diluted net loss per share of Class A Common Stock for each of the years ended December 31, 2022 and 2021. The reconciliation for 2021 reflects only the period from September 15, 2021 to December 31, 2021, which represents the period wherein the Company had outstanding Class A Common Stock.


(in thousands)	Year Ended December 31, 2022			Year Ended December 31, 2021
Numerator:
Net loss	$	(22,255	)	$	(61,257	)
Less: Net loss attributable to Definitive OpCo before Reorganization Transactions		—			(33,343	)
Less: Net loss attributable to noncontrolling interests		(16,218	)		(10,237	)
Net loss attributable to Definitive Healthcare Corp.	$	(6,037	)	$	(17,677	)

The following table sets forth the computation of basic and diluted net loss per share of Class A Common Stock:


(in thousands, except number of shares and per share amounts)	Year Ended December 31, 2022			Year Ended December 31, 2021
Basic net loss per share attributable to common stockholders
Numerator:
Allocation of net loss attributable to Definitive Healthcare Corp.	$	(6,037	)	$	(17,677	)
Weighted average number of shares of Class A outstanding		101,114,105			91,916,151
Net loss per share, basic and diluted	$	(0.06	)	$	(0.19	)

Shares of the Company's Class B Common Stock do not participate in the earnings or losses of Definitive Healthcare Corp. and are therefore not participating securities. As such, separate presentation of basic and diluted earnings per share of Class B Common Stock under the two-class method has not been presented.

The following securities were excluded from the computation of diluted net loss per share for the periods presented because their effect on net loss per share would have been anti-dilutive:


	Year Ended December 31, 2022		Year Ended December 31, 2021
Definitive OpCo units (vested and unvested)		50,433,101		58,244,627
Restricted stock units		3,563,387		2,100,250

Goodwill and Intangible Assets - Schedule of Intangible Assets and Goodwill (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	$ 552,524	$ 499,710
Accumulated Amortization	(201,802)	(147,240)
Net Carrying Amount	350,722	352,470
Goodwill [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,323,102	1,261,444
Accumulated Amortization	0	0
Net Carrying Amount	1,323,102	1,261,444
Goodwill And Intangible Assets [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	1,875,626	1,761,154
Accumulated Amortization	(201,802)	(147,240)
Net Carrying Amount	1,673,824	1,613,914
Customer Relationships [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	409,430	370,030
Accumulated Amortization	(128,745)	(92,942)
Net Carrying Amount	280,685	277,088
Developed Technologies [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	56,965	51,100
Accumulated Amortization	(25,514)	(17,475)
Net Carrying Amount	31,451	33,625
Trade Names [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	35,914	35,500
Accumulated Amortization	(7,150)	(5,034)
Net Carrying Amount	28,764	30,466
Data [Member]
Finite Lived Intangible Assets [Line Items]
Gross Carrying Amount	50,215	43,080
Accumulated Amortization	(40,393)	(31,789)
Net Carrying Amount	$ 9,822	$ 11,291

Income Taxes (Tables)

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Schedule Components Of Income Before Income Taxes

U.S. and foreign components of income before income taxes were as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Domestic	$	(34,617	)	$	(56,597	)	$	(49,610	)
Foreign		(4,823	)		(3,985	)		(1,547	)
Loss before income taxes	$	(39,440	)	$	(60,582	)	$	(51,157	)

Schedule of Components of Income Tax Provision

The components of the provision for income taxes are as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Current income taxes:
U.S. federal	$	82		$	(7	)	$	10
U.S. state and local		26			—			1
Total current income taxes	$	108		$	(7	)	$	11
Deferred income taxes:
U.S. federal	$	(1,024	)	$	369		$	58
U.S. state and local		(16,040	)		313			(7	)
Foreign		(229	)		—			—
Total deferred income taxes	$	(17,293	)	$	682		$	51
Income tax (benefit) expense	$	(17,185	)	$	675		$	62

Schedule of Reconciliation of the Statutory Federal Income Tax Rate to Income Tax Rate

The items accounting for the difference between income taxes computed at the U.S. federal statutory rate and our effective rate were as follows:


	Year Ended December 31,
(in thousands)	2022				2021				2020
Expected U.S. federal income taxes at statutory rate		21.00		%		21.00		%		21.00		%
Change in valuation allowance		(41.21	)			(13.94	)			0.60
State and local income taxes, net of federal benefit		40.53				(0.51	)			(0.14	)
Outside basis adjustment		19.95				8.90				—
Partnership income, not subject to taxation		(8.64	)			(19.44	)			(27.55	)
Return to provision		6.05				3.67				0.46
TRA remeasurement		4.99				—				—
Research and development credits		1.42				0.17				—
Foreign rate differential		1.35				(0.02	)			(0.01	)
Stock compensation		(1.23	)			—				—
Other		(0.64	)			(0.94	)			5.52
Effective income tax rate		43.57		%		(1.11	)	%		(0.12	)	%

Schedule of Components of Deferred Tax Assets And Liabilities

The components of deferred tax assets and liabilities were as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Deferred income tax assets:
Net operating loss carry forwards	$	52,534		$	38,540		$	1,517
Outside partnership basis difference		61,378			44,291			—
Tax receivable agreement		11,358			5,329			—
Other		1,131			824			74
Deferred income tax assets		126,401			88,984			1,591
Less valuation allowance		(187,807	)		(164,394	)		(1,430	)
Deferred income tax assets, net of valuation allowance	$	(61,406	)	$	(75,410	)	$	161
Deferred income tax liabilities:
Goodwill and intangibles	$	(14,126	)	$	(91	)	$	—
Deferred revenue and advances		(107	)		(229	)		—
Deferred income tax liabilities		(14,233	)		(320	)		—
Net deferred tax (liabilities) assets	$	(75,639	)	$	(75,730	)	$	161


	Year Ended December 31,
(in thousands)	2022			2021			2020
Reported as:
Non-current deferred tax assets (included within Other assets)	$	98		$	158		$	161
Non-current deferred tax liabilities		(75,737	)		(75,888	)		—
Net deferred tax assets (liabilities)	$	(75,639	)	$	(75,730	)	$	161

Summary of Significant Accounting Policies (Policies)

12 Months Ended

Dec. 31, 2022

Accounting Policies [Abstract]

Basis of Presentation

Principles of Consolidation

Use of Estimates in the Preparation of Financial Statements

Revenue Recognition

Fair Value Measurements

Level 1 - Observable inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities

Level 2 - Other inputs that are directly or indirectly observable in the marketplace

Level 3 - Unobservable inputs that are supported by little or no market activity, including the Company’s own assumptions in determining fair value.

Cash and Cash Equivalents

The Company considers all short-term, highly liquid investments with an original maturity of three months or less to be cash and cash equivalents.

Marketable Securities

Concentration of Credit Risk and Significant Customers

Accounts Receivable, Net and Contract Assets

Deferred Contract Costs

Property and Equipment, Net

Property and equipment are stated at cost, net of accumulated depreciation and amortization. The assets are depreciated on a straight-line basis over the estimated useful lives as follows:


Furniture and equipment	5 years
Computers and software	3 years
Leasehold improvements	Lesser of the asset life or lease term

Leases

Derivative Instruments and Hedging Activities

Advertising and Promotional Expenses

Software Development Costs

Acquisitions

Differences from these estimates are recorded in the consolidated statement of operations in the period in which they are identified.

Goodwill and Intangible Assets


Customer relationships	14 – 20 years
Technology	6 – 8 years
Tradenames / trademark	5 – 19 years
Data	3 years

Impairment of Long-Lived Assets

Equity-based Compensation

The Company classifies equity-based compensation expense in its consolidated statements of operations in the same manner in which the award recipient’s salary and related costs are classified.

Adoption of Recently Issued Financial Accounting Standards

quarter of 2022, the Company recorded contract liabilities of $3.4 million. Refer to Note 3. Acquisitions and Investments for further details.

Recently Issued Accounting Pronouncements Not Yet Adopted

Leases - Additional Information (Details) - USD ($)	3 Months Ended		6 Months Ended	12 Months Ended
Leases - Additional Information (Details) - USD ($)	Jun. 30, 2022	Mar. 31, 2022	Jun. 30, 2022	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Lessee, Lease, Description [Line Items]
Finance lease liability				$ 0
Finance Lease, Liability, Statement of Financial Position [Extensible Enumeration]				Other Liabilities, Noncurrent
Option to extend lease term				the Company gave notice of its intent to extend one of its office lease facilities for an additional five-year period and the extension was accounted for as a lease modification under ASC 842.
Lease existence of option to extend		true
Additional lease term period		5 years
Operating lease liability to be paid				$ 12,990,000	$ 16,441,000
Operating lease term of contract				4 years
Lease Payment				$ 1,800,000
Product Development [Member]
Lessee, Lease, Description [Line Items]
Rental Expenses				$ 2,400,000	$ 2,800,000	$ 1,800,000
Office Space Facilities [Member]
Lessee, Lease, Description [Line Items]
Operating lease liability to be paid	$ 6,000,000.0	$ 6,000,000.0	$ 6,000,000.0
Impairment charge	$ 200,000		$ 700,000
Minimum [Member] \| Office Space Facilities [Member]
Lessee, Lease, Description [Line Items]
Operating lease term of contract				1 year
Operating lease, renewal term				5 years
Maximum [Member] \| Office Space Facilities [Member]
Lessee, Lease, Description [Line Items]
Operating lease term of contract				9 years
Operating lease, renewal term				10 years

Derivative Instruments and Hedging Activities

12 Months Ended

Dec. 31, 2022

Derivative Instruments and Hedging Activities Disclosure [Abstract]

Derivative Instruments and Hedging Activities

11.

Derivative Instruments and Hedging Activities

Risk Management Objective of Using Derivatives

The Company is exposed to risks from changes in interest rates related to the 2021 Term Loan (See Note 10. Long-Term Debt). The Company uses derivative financial instruments, specifically, interest rate swap contracts, in order to manage its exposure to interest rate movements. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Our primary objective in holding derivatives is to reduce the volatility of cash flows associated with changes in interest rates. The Company does not enter into derivative transactions for speculative or trading purposes.

Cash Flow Hedges of Interest Rate Risk

The Company entered into two interest rate swap agreements, effective on March 31, 2022. Until October 31, 2022, the counterparties to each of the agreements paid the Company interest at a floating rate on the notional amounts based on the one-month USD-LIBOR swap rate. On October 31, 2022, in conjunction with the amendment to the 2021 Credit Agreement (See Note 10. Long-Term Debt), the Company amended the two interest rate swap agreements to replace the LIBO rate with Term SOFR. As a result, subsequent to October 31, 2022, the counterparties paid and will continue to pay interest at a floating rate based on Term SOFR.

As of December 31, 2022, the two outstanding interest rate swap agreements each had a notional value of $66.6 million with fixed interest rates of 1.909% and 1.9065%. Interest payments under the swaps are made monthly on a net settlement basis. The Company has not recorded any amounts due to ineffectiveness for the year ended December 31, 2022. The notional value of each interest rate swap agreement is expected to match the corresponding principal amount of a portion of our borrowings under the 2021 Term Loan. The swap agreements mature on March 31, 2025.

The derivative interest rate swaps are designated and qualify as cash flow hedges. Consequently, the change in the estimated fair value of the effective portion of the derivative is recognized in accumulated other comprehensive income (“AOCI”) on our consolidated balance sheets and reclassified to interest expense, net, when the underlying transaction has an impact on earnings. The Company expects to recognize approximately $3.7 million of net pre-tax gains from accumulated other comprehensive income as a reduction of interest expense in the next twelve months associated with its interest rate swaps. The Company recognizes derivative instruments and hedging activities on a gross basis as either assets or liabilities on the Company’s consolidated balance sheets and measures them at fair value. Hedge accounting generally provides for the matching of the timing of gain or loss recognition on the hedging instrument with the earnings effect of the hedged forecasted transactions in a cash flow hedge. To receive hedge accounting treatment, all hedging relationships are formally documented at the inception of the hedge, and the hedges must be highly effective in offsetting changes to future cash flows on hedged transactions.

The fair values of the interest rate swaps and their respective locations in our consolidated balance sheets at December 31, 2022 were as follows:


(in thousands)
Description	Balance Sheet Location	December 31, 2022
Short-term derivative asset	Prepaid expenses and other current assets	$	3,716
Long-term derivative asset	Other assets		2,834

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 146,934	$ 387,498
Short-term investments	184,939	0
Accounts receivable, net	58,799	43,336
Prepaid expenses and other current assets	12,686	6,518
Current portion of deferred contract costs	10,387	6,880
Total current assets	413,745	444,232
Property and equipment, net	4,464	5,069
Operating lease right-of-use assets, net	9,681	0
Other assets	4,683	8,431
Deferred contract costs, net of current portion	14,596	11,667
Investment in equity securities	0	32,675
Intangible assets, net	350,722	352,470
Goodwill	1,323,102	1,261,444
Total assets	2,120,993	2,115,988
Current liabilities:
Accounts payable	3,948	4,651
Accrued expenses and other current liabilities	18,748	22,658
Current portion of deferred revenue	99,692	83,611
Current portion of term loan	8,594	6,875
Current portion of operating lease liabilities	1,521	0
Total current liabilities	132,503	117,795
Long term liabilities:
Deferred revenue	236	412
Term loan, net of current portion	255,765	263,808
Operating lease liabilities, net of current portion	9,969	0
Tax receivable agreements liability	156,311	153,529
Deferred tax liabilities	75,737	75,888
Other long-term liabilities	3,251	1,294
Total liabilities	633,772	612,726
Commitments and Contingencies (Note 14)
Equity:
Additional paid-in capital	972,077	890,724
Accumulated other comprehensive income	3,668	62
Accumulated deficit	(23,714)	(17,677)
Noncontrolling interests	535,085	630,056
Total equity	1,487,221	1,503,262
Total liabilities and equity	2,120,993	2,115,988
Common Class A
Equity:
Common stock, value	105	97
Common Class B
Equity:
Common stock, value	$ 0	$ 0

Revenue - Summary of Deferred Revenue Balances (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Balance at beginning of year	$ 84,023	$ 61,200
Revenue recognized	(222,653)	(166,154)
Additional amounts deferred	238,558	188,977
Balance at end of year	$ 99,928	$ 84,023

Accounts Receivable - Schedule of Accounts Receivable (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Receivables [Abstract]
Accounts receivable	$ 59,780	$ 44,303
Unbilled receivable	881	430
Accounts Receivable, before Allowance for Credit Loss, Current	60,661	44,733
Less: allowance for doubtful accounts	(1,862)	(1,397)
Accounts receivable, net	$ 58,799	$ 43,336

Subsequent Events	12 Months Ended
Subsequent Events	Dec. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	On January 12, 2023, the Company announced a restructuring plan intended to reduce operating costs, improve operating margins, and continue advancing the Company’s ongoing commitment to profitable growth. The Company estimates that in the first quarter of 2023 it will incur pre-tax cash restructuring and related charges of approximately $2.0 million to $2.5 million, consisting primarily of severance payments, employee benefits, and related cash expenses, as well as an immaterial non-cash stock-based compensation charge related to the vesting of share-based awards for employees who are terminated. The Company expects these actions will be substantially complete by the end of the first quarter of 2023.

Revenue - Summary of Receivables, Deferred Contract Costs and Contract Liabilities from Contract with Customers (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 58,799	$ 43,336
Deferred contract costs	10,387	6,880
Long-term deferred contract costs	14,596	11,667
Deferred revenues	$ 99,928	$ 84,023

Equity-based Compensation (Tables)

12 Months Ended

Dec. 31, 2022

Summary of Equity Based Compensation Expense Recognized

A summary of the expense by line item in the consolidated statements of operations for the years ended December 31, 2022, 2021 and 2020, is provided in the following table.


	Year Ended December 31,
(in thousands)	2022		2021		2020
Cost of revenue	$	942	$	277	$	62
Sales and marketing		13,508		1,930		473
Product development		7,805		1,070		356
General and administrative		14,179		6,680		856
Total compensation expense	$	36,434	$	9,957	$	1,747

IPO

Schedule of Company’s Unvested Time-Based and Performance-Based Unit Activity

The following table summarizes the Company’s unvested unit activity.


	Time-Based
				Weighted
	Non-Vested			Average Grant
	Units			Date Fair Value
Unvested at December 31, 2021		2,756,406		$	2.02
Vested		(1,060,385	)		2.03
Forfeited		(186,872	)		2.03
Unvested at December 31, 2022		1,509,149		$	2.03

Time Based RSUs

Schedule of Company’s Unvested Time-Based and Performance-Based Unit Activity

The following table summarizes the Company's unvested time-based activity for the years ended December 31, 2022 and 2021:


	2022					2021
				Weighted					Weighted
	Restricted			Average Grant		Restricted			Average Grant
	Stock Units			Date Fair Value		Stock Units			Date Fair Value
Unvested at beginning of year		1,935,899		$	32.59		—		$	—
Granted		2,457,991		$	20.27		1,965,477		$	32.50
Vested		(716,776	)	$	29.86		—		$	—
Forfeited		(238,727	)	$	25.51		(29,578	)	$	27.00
Unvested at end of year		3,438,387		$	24.82		1,935,899		$	32.59

Performance-Based RSUs

Schedule of Company’s Unvested Time-Based and Performance-Based Unit Activity

The following table summarizes the Company's unvested PSU activity for the years ended December 31, 2022 and 2021:


	2022					2021
				Weighted				Weighted
	Restricted			Average Grant		Restricted		Average Grant
	Stock Units			Date Fair Value		Stock Units		Date Fair Value
Unvested at beginning of year		164,351		$	27.00		—	$	—
Granted		125,000		$	54.25		164,351	$	27.00
Vested		—		$	-		—	$	—
Forfeited		(164,351	)	$	27.00		—	$	—
Unvested at end of year		125,000		$	54.25		164,351	$	27.00

Fair Value Measurements

12 Months Ended

Dec. 31, 2022

Fair Value Disclosures [Abstract]

Fair Value Measurements

12.

Fair Value Measurements

ASC 820—Fair Value Measurements and Disclosures (“ASC 820”), defines fair value as the price that would be received for an asset, or paid to transfer a liability, in an orderly transaction between market participants on the measurement date, and establishes a three-level fair value hierarchy that prioritizes the inputs used to measure fair value as follows:

Level 1 - Observable inputs that reflect unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2 - Other inputs that are directly or indirectly observable in the marketplace.

Level 3 - Unobservable inputs that are supported by little or no market activity, including the Company’s own assumptions in determining fair value.

The Company’s financial assets and liabilities subject to the three-level fair value hierarchy consist principally of cash and equivalents, accounts receivable, accounts payable, long-term and short-term debt and contingent consideration payable. The estimated fair value of cash and equivalents, accounts receivable and accounts payable approximates their carrying value due to their short maturities (less than 12 months).

Debt

The Company’s term loans are recorded at their carrying values in the consolidated balance sheets, which may differ from their respective fair values. The estimated fair values of the Company’s term loans approximate their carrying values as of December 31, 2022 and 2021, based on interest rates currently available to the Company for similar borrowings.

Money market funds (included in cash and cash equivalents)

Money market funds are recorded at fair value using quoted market prices in active markets and are classified as Level 1 in the fair value hierarchy.

Short-term investments

The Company estimates the fair values of investments in U.S. treasuries, agency bond securities, commercial paper, and certificates of deposit using level 2 inputs, by taking into consideration valuations obtained from a third-party pricing service. The pricing services utilize industry standard valuation models, including both income and market-based approaches, for which all significant inputs are observable, either directly or indirectly, to estimate fair value. These inputs include reported trades of and broker/dealer quotes on the same or similar securities, issuer credit spreads, market yield curves, benchmark securities, prepayment/default projections based on historical data, and other observable inputs.

Derivative financial instruments

Currently, the Company uses interest rate swaps to manage interest rate risk. The valuation of these instruments is determined using widely accepted valuation techniques, including discounted cash flow analysis on the expected cash flows of each derivative. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities.

To comply with the provisions of ASC 820, the Company incorporates credit valuation adjustments to appropriately reflect both its own nonperformance risk and the respective counterparty’s nonperformance risk in the fair value measurements.

Although the Company has determined that the majority of the inputs used to value its derivatives fall within Level 2 of the fair value hierarchy, the credit valuation adjustments associated with its derivatives utilize Level 3 inputs, such as estimates of current credit spreads to evaluate the likelihood of default by the Company and its counterparties. The Company has determined that the significance of the impact of the credit valuation adjustments made to its derivative contracts, which determination was based on the fair value of each individual contract, was not significant to the overall valuation. As a result, all of its derivatives held as of December 31, 2022 were classified as Level 2 in the fair value hierarchy.

Contingent consideration

The deferred consideration that resulted from the acquisition of Analytical Wizards in the first quarter of 2022, which is subject to the meeting of certain expense control metrics during the two-year period following the AW acquisition, is measured at fair value on a recurring basis. The fair value was estimated based on the present value of the amount expected to be paid at the end of the measurement period. At December 31, 2022, the fair value of the contingent consideration was estimated to be $2.3 million based on the estimated achievement of the expense control metrics and time to payment and is included in other long-term liabilities on the consolidated balance sheet.

The contingent consideration that resulted from the earnouts associated with the acquisition of Monocl Holding Company in October of 2020, which was included in accrued expense and other current liabilities in the consolidated balance sheet as of December 31, 2021, was paid in the first quarter of 2022.

Earnout liabilities are classified within Level 3 in the fair value hierarchy because the methodology used to develop the estimated fair value includes significant unobservable inputs reflecting management’s own assumptions. The table below presents a reconciliation of earnout liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	7,500		$	5,236
Additions		1,000			—
Net change in fair value and other adjustments		1,250			3,764
Payments		(7,500	)		(1,500	)
Balance at end of year	$	2,250		$	7,500

Non-recurring fair value measurements

Certain assets and liabilities, including property, plant and equipment, lease right-of-use assets, goodwill and other intangible assets, are measured at fair value on a non-recurring basis. These assets are remeasured when the derived fair value is below the carrying value on the Company’s consolidated balance sheet. For these assets, the Company does not periodically adjust carrying value to fair value except in the event of impairment. When impairment has occurred, the Company measures the required charges and adjusts the carrying value as discussed in Note 2. Summary of Significant Accounting Policies. For discussion about the impairment testing of assets not measured at fair value on a recurring basis see Note 9. Goodwill and Intangible Assets for additional details.

During the second quarter of 2022, in relation to our office relocations, the Company recorded an impairment charge of $1.0 million, comprised of $0.9 million relating to the operating lease right-of-use assets, and $0.1 million relating to the leasehold improvements. The fair value determination was based on valuation techniques using the best information available and included comparable market information and discounted cash flow projections.

At December 31, 2022, assets and liabilities measured at fair value on a recurring basis were as follows:


(in thousands)	Total		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Money market funds	$	39,523	$	39,523	$	—	$	—
Commercial paper (maturities less than 90 days)		2,276		—		2,276		—
Certificates of deposit (maturities less than 90 days)		1,549		—		1,549		—
Agency bonds (maturities less than 90 days)		768		—		768		—
Short-term investments:
U.S. treasuries		59,723		—		59,723		—
Agency bonds		6,452		—		6,452		—
Commercial paper		95,737		—		95,737		—
Certificates of deposit		23,027		—		23,027		—
Prepaid expenses and other current assets:
Interest rate swap contracts		3,716		—		3,716		—
Other assets:
Interest rate swap contracts		2,834		—		2,834		—
Liabilities:
Other long-term liabilities:
Contingent consideration		2,250		—		—		2,250

At December 31, 2022, except for the contingent consideration noted above, the estimated fair values of all of the Company’s financial assets and liabilities subject to the three-level fair value hierarchy approximated their carrying values due to their short-term maturities (less than 12 months).

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References + Details

Fair Value Measurements (Tables)

12 Months Ended

Dec. 31, 2022

Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Abstract]

Schedule of Reconciliation of Earnout Liabilities Measured at Fair Value on a Recurring Basis Unobservable Inputs

The table below presents a reconciliation of earnout liabilities measured at fair value on a recurring basis using significant unobservable inputs (Level 3):


(in thousands)	December 31, 2022			December 31, 2021
Balance at beginning of year	$	7,500		$	5,236
Additions		1,000			—
Net change in fair value and other adjustments		1,250			3,764
Payments		(7,500	)		(1,500	)
Balance at end of year	$	2,250		$	7,500

Schedule of Fair Value of Assets and Liabilities Measured at Fair Value on Recurring Basis

At December 31, 2022, assets and liabilities measured at fair value on a recurring basis were as follows:


(in thousands)	Total		Level 1		Level 2		Level 3
Assets:
Cash and cash equivalents:
Money market funds	$	39,523	$	39,523	$	—	$	—
Commercial paper (maturities less than 90 days)		2,276		—		2,276		—
Certificates of deposit (maturities less than 90 days)		1,549		—		1,549		—
Agency bonds (maturities less than 90 days)		768		—		768		—
Short-term investments:
U.S. treasuries		59,723		—		59,723		—
Agency bonds		6,452		—		6,452		—
Commercial paper		95,737		—		95,737		—
Certificates of deposit		23,027		—		23,027		—
Prepaid expenses and other current assets:
Interest rate swap contracts		3,716		—		3,716		—
Other assets:
Interest rate swap contracts		2,834		—		2,834		—
Liabilities:
Other long-term liabilities:
Contingent consideration		2,250		—		—		2,250

Goodwill and Intangible Assets - Schedule of Future Amortization Expense (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 49,833
2024	46,986
2025	42,420
2026	34,888
2027	28,559
Thereafter	148,036
Net Carrying Amount	$ 350,722	$ 352,470

Income Taxes

12 Months Ended

Dec. 31, 2022

Income Tax Disclosure [Abstract]

Income Taxes

19.

Income Taxes

As described in Note 1. Description of Business, as a result of the IPO, the Company began consolidating the financial results of Definitive OpCo. Definitive OpCo is treated as a partnership for U.S. federal and most applicable state and local income tax purposes. As a partnership, Definitive OpCo is generally not subject to U.S. federal and certain state and local income taxes. Any taxable income or loss generated by Definitive OpCo is passed through to and included in the taxable income or loss of its members, including Definitive Healthcare Corp., based on its economic interest held in Definitive OpCo. Definitive Healthcare Corp. was formed on May 5, 2021 and did not engage in any operations prior to the IPO. Definitive HealthCare Corp. is taxed as a corporation and is subject to U.S. federal, state, and local income taxes with respect to its allocable share of any taxable income or loss of Definitive OpCo, as well as any such taxes on stand-alone income or loss generated by the Company. HSE, Monocl, AW and subsidiaries are taxed as corporations and are subject to U.S. federal, state, and local income taxes.

Income Tax Expense

U.S. and foreign components of income before income taxes were as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Domestic	$	(34,617	)	$	(56,597	)	$	(49,610	)
Foreign		(4,823	)		(3,985	)		(1,547	)
Loss before income taxes	$	(39,440	)	$	(60,582	)	$	(51,157	)

The components of the provision for income taxes are as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Current income taxes:
U.S. federal	$	82		$	(7	)	$	10
U.S. state and local		26			—			1
Total current income taxes	$	108		$	(7	)	$	11
Deferred income taxes:
U.S. federal	$	(1,024	)	$	369		$	58
U.S. state and local		(16,040	)		313			(7	)
Foreign		(229	)		—			—
Total deferred income taxes	$	(17,293	)	$	682		$	51
Income tax (benefit) expense	$	(17,185	)	$	675		$	62

Effective Income Tax Rate

The items accounting for the difference between income taxes computed at the U.S. federal statutory rate and our effective rate were as follows:


	Year Ended December 31,
(in thousands)	2022				2021				2020
Expected U.S. federal income taxes at statutory rate		21.00		%		21.00		%		21.00		%
Change in valuation allowance		(41.21	)			(13.94	)			0.60
State and local income taxes, net of federal benefit		40.53				(0.51	)			(0.14	)
Outside basis adjustment		19.95				8.90				—
Partnership income, not subject to taxation		(8.64	)			(19.44	)			(27.55	)
Return to provision		6.05				3.67				0.46
TRA remeasurement		4.99				—				—
Research and development credits		1.42				0.17				—
Foreign rate differential		1.35				(0.02	)			(0.01	)
Stock compensation		(1.23	)			—				—
Other		(0.64	)			(0.94	)			5.52
Effective income tax rate		43.57		%		(1.11	)	%		(0.12	)	%

Deferred Tax Assets and Liabilities

The components of deferred tax assets and liabilities were as follows:


	Year Ended December 31,
(in thousands)	2022			2021			2020
Deferred income tax assets:
Net operating loss carry forwards	$	52,534		$	38,540		$	1,517
Outside partnership basis difference		61,378			44,291			—
Tax receivable agreement		11,358			5,329			—
Other		1,131			824			74
Deferred income tax assets		126,401			88,984			1,591
Less valuation allowance		(187,807	)		(164,394	)		(1,430	)
Deferred income tax assets, net of valuation allowance	$	(61,406	)	$	(75,410	)	$	161
Deferred income tax liabilities:
Goodwill and intangibles	$	(14,126	)	$	(91	)	$	—
Deferred revenue and advances		(107	)		(229	)		—
Deferred income tax liabilities		(14,233	)		(320	)		—
Net deferred tax (liabilities) assets	$	(75,639	)	$	(75,730	)	$	161


	Year Ended December 31,
(in thousands)	2022			2021			2020
Reported as:
Non-current deferred tax assets (included within Other assets)	$	98		$	158		$	161
Non-current deferred tax liabilities		(75,737	)		(75,888	)		—
Net deferred tax assets (liabilities)	$	(75,639	)	$	(75,730	)	$	161

Deferred income tax balances reflect the effects of temporary differences between the carrying amounts of assets and liabilities and their tax bases and are stated at enacted tax rates expected to be in effect when the taxes are paid or recovered.

The federal tax loss carryforward of $192.1 million has an unlimited carryforward period. The federal research and development tax credit carryforwards of $0.7 million expires in the years 2040 through 2042. The state tax loss carryforwards of $147.2 million expires at various times in years 2022 through indefinite. The state tax credit carryforwards of $0.3 million expires in the years 2037 through indefinite. The foreign tax loss carryforward of $14.0 million expires in the years 2030 through indefinite.

Management has assessed the realizability of deferred tax assets. Based on the review of all available evidence, the Company determined that it has not yet attained a sustained level of profitability and the objectively verifiable negative evidence outweighed the positive evidence. Therefore, the Company has recorded a valuation allowance for all three years on its net operating loss carryforwards, R&D credit carryforwards and other net deferred tax assets that remain after all sources of taxable income are exhausted, not supportable by the “naked credit” deferred tax liability sourced income as of December 31, 2022. In the event that management was to determine that the Company would be able to realize its deferred tax assets in the future in excess of their net recorded amount, an adjustment to the valuation allowance would be made which would reduce the provision for income taxes.

Uncertain Tax Positions

The Company recognizes the financial statement effects of tax positions when it is more-likely-than-not the position will be sustained upon examination. As of December 31, 2022 and 2021, the Company has not identified any uncertain tax positions and has not recognized any related reserves. Accordingly, the Company has not recorded any interest or penalties associated with uncertain tax positions.

Tax Receivable Agreement

Pursuant to Definitive OpCo's election under Section 754 of the Internal Revenue Code (the “Code”), Definitive Healthcare Corp. expects to obtain an increase in its share of the tax basis in the net assets of Definitive OpCo when LLC Interests are redeemed or exchanged by other members. The Company is required to adjust the basis of partnership assets under Section 743(b) of the Code for each taxable year in which a redemption or exchange of LLC Interest occurs. These increases in tax basis may reduce the amounts that would otherwise be paid by the Company in the future to various tax authorities. They may also decrease gains (or increase losses) on future dispositions of certain capital assets to the extent tax basis is allocated to those capital assets.

Under the TRA, the Company generally will be required to pay to the TRA Parties 85% of the amount of cash savings, if any, in U.S. federal, state, or local tax that the Company actually realizes directly or indirectly (or are deemed to realize in certain circumstances) as a result of (i) certain tax attributes acquired by the Company from the Blocker Companies in the Reorganization Transactions, (ii) certain tax basis adjustments resulting from (a) acquisitions by the Company of LLC Units from pre-IPO holders in connection with the IPO and (b) subsequent redemptions or exchanges of LLC Units by holders for Class A Common Stock or other consideration, and (iii) certain payments made under the TRA. The Company expects to benefit from the remaining 15% of any tax benefits that it may actually realize. To the extent that the Company is unable to timely make payments under the TRA for any reason, such payments generally will be deferred and will accrue interest until paid.

Amounts payable under the TRA are contingent upon, among other things, (i) generation of future taxable income over the term of the TRA, and (ii) future changes in tax laws. If the Company does not generate sufficient taxable income in the aggregate over the term of the TRA to utilize the tax benefits, then the Company would not be required to make the related TRA payments. Therefore, the Company only recognizes a liability for the TRA if it determines whether it is probable that it will generate sufficient future taxable income over the term of the TRA to utilize the related tax benefits. Estimating future taxable income is inherently uncertain and requires judgment. The realizability of the deferred tax assets is evaluated based on all positive and negative evidence, including future reversals of existing taxable temporary differences, projected future taxable income, tax planning strategies, and recent results of operations. Based on current projections, the Company anticipates having sufficient taxable income to partially realize some of these benefits and has recorded a TRA liability of $156.3 million as of December 31, 2022. The TRA liability increased by $2.8 million during the year ended December 31, 2022, increasing $12.2 million with an offsetting adjustment to accumulated paid-in capital for current year LLC unit exchanges, while concurrently decreasing by $9.4 million for remeasurement of the liability based on future realizability of tax attributes with an offsetting adjustment to other income, net in the consolidated statements of operations. The Company did not make any payments on its TRA liability during the year. To the extent that the Company determines that it is able to realize the tax benefits associated with the basis adjustments and net operating losses, the Company would record an additional liability of $109.1 million for a total liability of $265.4 million. Should the Company anticipate a reduction in future taxable income, it would record a reduction in the TRA liability that would result in a benefit recorded within the consolidated statements of operations.

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 21
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319

Reference 2: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SAB Topic 11.C)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 17
-Subparagraph (b)
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319

Reference 4: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SAB TOPIC 6.I.5.Q1)
-URI https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 10
-Section 50
-Paragraph 14
-URI https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 270
-Section 50
-Paragraph 1
-URI https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-URI https://asc.fasb.org/topic&trid=2144680

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 740
-SubTopic 30
-Section 50
-Paragraph 2
-Subparagraph (a)
-URI https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(h)(2))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

+ Details

CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($)
$ in Thousands

12 Months Ended

Dec. 31, 2022

Dec. 31, 2021

Dec. 31, 2020

Income Statement [Abstract]

Revenue

$ 222,653

$ 166,154

$ 118,317

Cost of revenue:

Cost of revenue exclusive of amortization

25,866

19,421

11,085

Amortization

16,759

21,268

19,383

Gross profit

180,028

125,465

87,849

Operating expenses:

Sales and marketing

89,585

56,387

34,332

Product development

34,890

18,565

11,062

General and administrative

48,781

30,528

12,927

Depreciation and amortization

40,145

38,679

40,197

Transaction, integration and restructuring expenses

7,890

6,287

3,776

Total operating expenses

221,291

150,446

102,294

Loss from operations

(41,263)

(24,981)

(14,445)

Other income (expense), net:

Other income (expense), net:

10,236

143

(222)

Interest expense, net

(8,413)

(25,871)

(36,490)

Loss on extinguishment of debt

(9,873)

Total other income (expense), net

1,823

(35,601)

(36,712)

Loss before income taxes

(39,440)

(60,582)

(51,157)

Benefit from (provision for) income taxes

17,185

(675)

Net loss

(22,255)

(61,257)

(51,157)

Less: Net loss attributable to Definitive OpCo prior to the Reorganization Transactions

(33,343)

(51,157)

Less: Net loss attributable to noncontrolling interests

(16,218)

(10,237)

Net loss attributable to Definitive Healthcare Corp.

$ (6,037)

$ (17,677)

$ 0

Net loss per share of Class A Common Stock:

Basic and diluted

$ (0.06)

$ (0.19)

Basic and diluted

$ (0.06)

$ (0.19)

Weighted average Common Stock outstanding:

Basic and diluted

^[1]

101,114,105

91,916,151

Basic and diluted

^[1]

101,114,105

91,916,151

[1]

Revenue - Summary of Remaining Performance Obligation (Details) - USD ($) $ in Thousands	Dec. 31, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Current	$ 183,527	$ 155,134
Non-current	93,464	95,354
Total	$ 276,991	$ 250,488

Loss Per Share (Tables)

12 Months Ended

Dec. 31, 2022

Earnings Per Share [Abstract]

Schedule of Net Loss Per Share, Basic and Diluted


(in thousands)	Year Ended December 31, 2022			Year Ended December 31, 2021
Numerator:
Net loss	$	(22,255	)	$	(61,257	)
Less: Net loss attributable to Definitive OpCo before Reorganization Transactions		—			(33,343	)
Less: Net loss attributable to noncontrolling interests		(16,218	)		(10,237	)
Net loss attributable to Definitive Healthcare Corp.	$	(6,037	)	$	(17,677	)

The following table sets forth the computation of basic and diluted net loss per share of Class A Common Stock:


(in thousands, except number of shares and per share amounts)	Year Ended December 31, 2022			Year Ended December 31, 2021
Basic net loss per share attributable to common stockholders
Numerator:
Allocation of net loss attributable to Definitive Healthcare Corp.	$	(6,037	)	$	(17,677	)
Weighted average number of shares of Class A outstanding		101,114,105			91,916,151
Net loss per share, basic and diluted	$	(0.06	)	$	(0.19	)

Schedule of Dilutive Securities Excluded from Computation of Diluted Net Loss Per Share

The following securities were excluded from the computation of diluted net loss per share for the periods presented because their effect on net loss per share would have been anti-dilutive:


	Year Ended December 31, 2022		Year Ended December 31, 2021
Definitive OpCo units (vested and unvested)		50,433,101		58,244,627
Restricted stock units		3,563,387		2,100,250

Long Term Debt (Tables)

12 Months Ended

Dec. 31, 2022

Long-Term Debt, Unclassified [Abstract]

Schedule of Long-term Debt

Long-term debt consisted of the following as of December 31, 2022 and 2021, respectively:


	December 31, 2022
(in thousands)	Principal		Unamortized debt issuance costs / financing costs			Total debt, net
2021 Term Loan	$	266,406	$	(2,047	)	$	264,359
Less: current portion of long-term debt							8,594
Long-term debt						$	255,765


	December 31, 2021
(in thousands)	Principal		Unamortized debt issuance costs / financing costs			Total debt, net
2021 Term Loan	$	273,282	$	(2,599	)	$	270,683
Less: current portion of long-term debt							6,875
Long-term debt						$	263,808

Schedule of Debt

The expected future principal payments as of December 31, 2022 are as follows:


(in thousands)
2023	$	8,593
2024		13,750
2025		13,750
2026		230,313
	$	266,406

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 3
-Subparagraph (SX 210.12-04(a))
-URI https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644

Reference 5: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69B
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399

Reference 7: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 470
-SubTopic 20
-Section 55
-Paragraph 69E
-URI https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644

+ Details

Description of Business - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			12 Months Ended
	Nov. 22, 2021	Sep. 17, 2021	Dec. 31, 2022
Entity Incorporation, Date of Incorporation			May 31, 2021
Acquisition of Limited Liability Company (LLC)		14,222,222
Purchase Of Limited Liability Company (LLC) Unit		1,169,378
Fee and Expense			$ 11.4
Common Class A
Issuance of Class A common stock in IPO net of costs, Share		17,888,888
Share Price		$ 27.00
Proceeds from Issuance Initial Public Offering		$ 452.8
Repurchase of share, Shares		2,497,288
Follow-On Offering [Member] \| Common Class A
Issuance of Class A common stock in IPO net of costs, Share	11,000,000
Share Price	$ 36.00
Proceeds from Issuance Initial Public Offering	$ 382.1
IPO
Proceeds to repay outstanding debt			$ 199.6
Definitive OpCo [Member] \| Follow-On Offering [Member]
Acquisition of Limited Liability Company (LLC)	7,000,000
Purchase Of Limited Liability Company (LLC) Unit	1,766,762
Fee and Expense	$ 1.6
Definitive OpCo [Member] \| Follow-On Offering [Member] \| Common Class A
Repurchase of share, Shares	2,233,238